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ABSTRACT 
 
 
 Non-typhoidal salmonellae are zoonotic pathogens that cause the largest 
number of cases of bacterial foodborne gastroenteritis in the United States 
annually. Food products of animal origin contaminated with Salmonella are 
major sources for human infection in the United States with food products of 
bovine origin responsible for up to 30% of all outbreaks of human disease. 
Salmonellae are heavily studied pathogens due to the ease of genetic 
manipulation and rapid growth rate. However, despite thorough investigation of 
Salmonella virulence mechanisms over the past three decades, few studies 
have used relevant animal models to study the gastrointestinal phase of 
infection. In addition, the vast majority of inquiry has focused on few virulence 
loci, leaving approximately half of the genome poorly explored.  
 We used the calf, a natural host of Salmonella and model that most closely 
recapitulates early enteric infection, to identify new Salmonella genes needed for 
infection and further characterized a subset of these genes. We identified more 
than 20 genes never previously implicated in enteric infection and confirmed the 
necessity of two genes, STM3846 (retron reverse transcriptase) and STM3602 
(transcriptional regulator), during infection of the calf. Additional exploration 
using both mouse models and in vitro experiments showed that the STM3846 
reverse transcriptase produces a RNA-DNA hybrid molecule called multicopy 
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single-stranded DNA. This molecule regulates protein abundance during 
anaerobiosis, leading to poor colonization of mutants unable to produce this 
molecule. Further characterization of STM3602 showed that this putative 
transcriptional regulator is involved in regulating multiple processes that are 
necessary for Salmonella to thrive within the complex microbial community of 
the intestine. Thus, through the use of a carefully orchestrated genetic screen in 
a relevant animal host, novel genes were identified and their functions for 
colonization characterized. These genes and the processes in which they 
participate are potential targets for development of novel therapeutics to combat 
this increasingly antibiotic resistant pathogen. 
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CHAPTER I 
INTRODUCTION AND LITERATURE REVIEW 
 
 Salmonella enterica is zoonotic pathogen of substantial concern to global 
human and animal health. It is a leading cause of morbidity and mortality in 
people worldwide [1, 2]. Infection with Salmonella arises from consumption of 
contaminated food or water or direct contact with an infected individual or animal 
[3, 4]. Infected individuals and animals may shed billions of organisms per gram 
of feces and represent a major source of environmental contamination, 
particularly in areas where sanitation is poor.  
 There are two major disease syndromes associated with Salmonella 
infection, enteric disease and systemic disease, although these disease 
syndromes are not mutually exclusive. Enteric disease caused by non-typhoidal 
Salmonella (NTS) persists for as long as one week and is characterized by 
fever, abdominal cramping, diarrhea, vomiting, and weight loss [5-8]. It is 
estimated that more than 90 million cases of NTS occur worldwide each year [9]. 
Uncomplicated NTS infection generally resolves without specific treatment in 
immunocompetent hosts. Immunosuppressed individuals, children under the age 
of 5, and the elderly may develop life-threatening bacteremia as a sequel to 
enteric disease [5]. Pathologic lesions of NTS are observed primarily within the 
ileum, cecum, and colon. Enteric disease is characterized histologically by 
mucosal edema and ulceration, neutrophilic inflammatory infiltrates, hyperplasia 
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of Peyer’s patches and mesenteric lymph nodes, and crypt degeneration and 
abscessation [10-12]. Regardless of the severity of disease, one important 
characteristic of Salmonella infection is subclinical carriage with intermittent fecal 
shedding of organisms [8]. This subclinical persistence represents an important 
reservoir for continued environmental contamination. 
 Typhoid fever is caused by the host-adapted serotypes of Salmonella: 
Typhi, Paratyphi A, B, and C for humans [13]. A conservative estimate of the 
global burden of Typhoid and Paratyphoid fever is more than 13 million cases 
annually [14]. Typhoid fever is characterized by fever, headache, anorexia, and 
general malaise with symptoms lasting as long as 3 weeks [13, 15]. Only 
approximately one-third of patients with this systemic disease develop 
gastrointestinal manifestations. Treatment with antibiotics is required for 
successful resolution of systemic disease.  
 The pathologic lesions seen in Typhoid fever differ from those of 
Salmonella enterocolitis. Typhoid fever is characterized by granulomatous 
inflammation with mononuclear cell infiltrates in the intestine particularly 
centered over Peyer’s patches, and diffusely throughout the liver and spleen [16, 
17]. There is a relative paucity of neutrophil involvement as compared with the 
disease syndrome created by NTS. As with NTS, chronic carriage develops in 
up to 5% of patients leading to intermittent fecal shedding and chronic carriers 
are considered the main reservoirs of the typhoidal serotypes [18].  
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 Salmonellae are facultative intracellular pathogens, capable of colonizing 
and causing disease in all species of mammals and birds. However, salmonellae 
may also live on abiotic surfaces and can remain in soil for more than 300 days 
in permissive conditions (reviewed in [19]). Even plants cultivated in Salmonella-
infested soil may become culture-positive via a variety of mechanisms [20]. 
Studies on the biology of the organism in the laboratory environment poorly 
replicate the environmental pressures to which the organism is exposed. It is, 
therefore, essential to study this pathogen in its natural environment, during 
infection of a host, in order to understand pathogenic mechanisms. A recent 
World Health Organization report suggests that multidrug resistant (MDR) 
salmonellae are an emerging food-borne threat with some areas reporting more 
than 90% of human infections caused by MDR salmonellae [21]. This fact, as 
well as the emergence of Salmonella strains with increasing potential to cause 
deadly disease [22], drive the need for further research to develop new 
antibacterial strategies and improved vaccines. 
 In the work presented here, I will discuss enteric salmonellosis, 
particularly that caused by Salmonella Typhimurium (STm). I will briefly discuss 
the epidemiology of NTS from animal sources and describe two complementary 
animal models of enteric disease. I will also describe the accepted strategies 
used by Salmonella to colonize the mammalian intestine. Finally, I will provide 
the framework for the discussion of two novel strategies of intestinal colonization 
that are detailed in the following chapters. 
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Animal sources of salmonellae 
 Animals of agricultural importance are frequently colonized with 
salmonellae. These animals are a source for environmental contamination by 
infected animal waste and are a direct route to contamination of the food supply. 
There is also an animal welfare concern for those that develop clinical disease. 
In a survey of 403 food-borne Salmonella outbreaks in the United States (US), 
products of the poultry industry (eggs, chicken, and turkey) accounted for 50.6% 
of outbreaks, bovine products (beef and dairy) accounted for 12.2% of 
outbreaks, and pork products for 9.1% of outbreaks [23]. The absolute number 
of non-outbreak cases attributable to a given food source varies but the trends 
are similar [3, 24]. It is apparent from these data that food products of animal 
origin are major sources of Salmonella cases and outbreaks. 
 However, the relative contribution of different agricultural animals to total 
numbers of human enteric salmonellosis cases in the US annually is difficult to 
estimate. Humans may become infected from direct contact with animals that 
are shedding Salmonella [4]. Animal waste may be released into the 
environment where infectious agents may gain access to growing crops and/or 
the water supply. In addition, rodents, raccoons, birds, and insects may gain 
access to production animals or their waste products when animals are reared in 
systems without strict isolation from the external environment. Both waste 
contamination of the environment and potential colonization of wild animals may 
lead to dissemination of salmonellae and other infectious agents from the point 
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of animal production, and the relative impact would be difficult to monitor. Thus, 
it is possible that agricultural animals are important sources of contamination of 
non-animal food products that may be point sources for outbreaks in the human 
population. There is a complex interplay between animals, the environment, and 
humans for transmission of Salmonella and for generation of outbreaks with 
potential devastating consequences. 
 
Animal models of disease  
 Using animals to model infectious disease is a common practice with the 
overall goal of understanding the disease process in order to create 
interventions that will treat or prevent the development of disease. When 
modeling disease, there are some important points to consider. Desirable 
characteristics of an animal model are that the disease resembles human 
disease in the organ affected, histologic appearance of lesions, and immune 
response to the invading organism. Other desirable characteristics include the 
ready availability of animals with defined husbandry and an affordable cost of 
animal purchase and housing. In order to study the host response to disease, 
models that have a sequenced genome and are genetically tractable are 
preferred. Finally, the animal’s capacity to metabolize xenobiotic compounds 
and immune responses must be considered in order to test the efficacy of new 
therapeutics and vaccines. It is not possible to fulfill all of these requirements for 
each animal model, but these characteristics must be considered and any lack 
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of concordance recognized when choosing an animal species to use as a model 
system.  
 
Murine colitis model 
 Mice are the most highly utilized animal to model salmonellosis. Mice of 
the C57B6 lineage do not develop diarrheal disease after oral infection with 
NTS, but instead the organisms disseminate systemically and colonize the 
internal organs (murine typhoid model). Pathology in the intestine is mild, and is 
characterized by infiltrates of mononuclear cells [25]. Colonization resistance 
mediated by the microbiota, makes the mouse a poor model to study enteric 
salmonellosis (reviewed in [26, 27]).  
 The murine colitis model was developed in order to overcome these 
limitations. In this model, mice are treated with streptomycin to reduce the 
intestinal microflora prior to infection with Salmonella [28, 29]. Salmonella 
Typhimurium colonizes the cecum in these streptomycin-pretreated mice with 
high efficiency, and induces a severe inflammatory response (reviewed in [30-
32]). The inflammatory response is characterized by neutrophil and mononuclear 
cell infiltration, submucosal edema, crypt abscessation, villous blunting and 
fusion, and epithelial damage. These histologic indicators of disease are similar 
to those observed in cases of enteric salmonellosis in people. However, the 
primary histologic abnormalities found in this model are within the cecum, with 
relatively little inflammation evident within the ileum or colon 2 to 4 days post 
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infection (Figure 1.1 and reference [33]). Thus, this model might be more 
appropriately termed the murine typhlitis model to describe the severe cecal 
inflammation and relative paucity of inflammatory changes in the colon. While 
the cecum is affected in human cases of enteric salmonellosis, a more diffuse 
enterocolitis is also observed [10-12]. The difference in disease localization is 
important to note as the different portions of the gastrointestinal tract have highly 
diverse functions in digestion, microbial community complexity and composition, 
and may have different responses to infection.  
 Inbred C57BL/6 mice are the most heavily used for the murine colitis 
model [28]. These mice are highly susceptible to infection with intracellular 
pathogens because they lack a functional Natural Resistance Associated 
Macrophage Protein-1 (NRAMP-1) gene (SLC11A1), encoding an exporter of 
divalent cations from the phagosome [34]. Cells lacking NRAMP-1 permit growth 
of pathogens within phagosomes [34]. In mice, the NRAMP gene is highly 
expressed within cells of the myeloid lineage in numerous organs including the 
intestine [35]. This protein is important for adequate innate immune response to 
Salmonella in mice as mortality rates after Salmonella infection are substantially 
greater in NRAMP-/- mice as opposed to those that are NRAMP+/+ after 
intravenous Salmonella challenge [36].  
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Figure 1.1: Intestinal histopathology from the murine models of salmonellosis. 
Representative images of intestinal segments from mice euthanized four days after oral 
infection with 108 colony forming units of virulent Salmonella Typhimurium. (A-C) Murine 
typhoid model showing no observed inflammatory changes in (A) ileum, (B) cecum, or (C) 
large intestine. (D-F) Murine colitis model with extreme variation in the inflammatory 
response between intestinal segments. (D) Ileum with mild mononuclear leukocyte 
infiltration and epithelial damage. (E) Cecum with submucosal edema (arrow), severe 
neutrophilic inflammation (arrowhead) and mononuclear leukocyte infiltration, and severe 
epithelial damage. (F) Large intestine with mild mononuclear leukocyte infiltration. 
Horizontal bars are 100 µm. 
 
 
A. B. C. 
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 Interestingly, NRAMP+/+ mice rarely succumb to infection and may live for 
more than 1 year harboring the pathogen [37]. The murine colitis model has 
been described in NRAMP+/+ mice and they develop similar disease with similar 
histologic abnormalities observed in NRAMP-/- mice [38]. The major advantage 
of this model is that mice survive the acute infection, which allows for monitoring 
the development of protective immunity, epithelial restitution following acute 
disease, and for evaluating therapeutic efficacy. This model may have utility for 
the study of factors responsible for chronic shedding of NTS, a factor 
contributing to the contamination of the food supply. 
 The murine colitis models have substantial value and have contributed to 
our knowledge of the pathogenesis of enteric disease. Mice are inexpensive, do 
not require specialized facilities for housing, handling skills are easily learned, 
the genome sequence is available, and there are invaluable genetic tools 
available to study the host response. However, the major limitation of mice as 
model organisms for the study of enteric disease is the necessity to disrupt the 
microflora prior to infection. This fact makes it impossible to use this model to 
assess microbiota-mediated factors Salmonella encounters during infection of a 
natural host. Secondly, the use of inbred animals to model host response fails to 
encompass the range of disease responses in an outbred population naturally 
acquiring infection as has been shown for other bacterial and viral pathogens 
using outbred mouse strains [39, 40]. In addition, there has been recent debate 
as to the utility of the mouse to model human inflammatory disease [41]. While 
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much valuable information regarding the pathogenesis and host response to 
Salmonella infection has been elucidated using murine models of infection, there 
is no replacement for the study of disease in a natural host. 
 
Bovine enteritis models 
 Cattle are natural hosts of salmonellae and are a source of contamination 
of the environment and food products [23, 24]. As natural hosts of this organism, 
cattle are susceptible to all of the syndromes of salmonellosis: acute or chronic 
diarrheal disease, bacteremia and systemic disease, or subclinical carriage and 
prolonged fecal shedding [42]. Cattle are susceptible to all non-typhoidal 
serotypes and serotype Dublin is host-adapted to cause bacteremia and 
systemic disease in cattle.  
 Susceptibility to disease is age-dependent as younger calves are more 
prone to severe disease and death from Salmonella infection [43], as is the case 
for human infection. However, older animals will also become infected and can 
develop diarrheal disease and serve as a reservoir for continual environmental 
contamination [42]. Enteric disease is characterized by high fever, inappetence, 
signs of abdominal discomfort, and diarrhea [44]. Clinical signs persist for up to 
10 days and infected animals may consistently shed the organism in feces for as 
many as 20 days and intermittently for as many as 7 weeks [44]. The tissues 
with the largest bacterial burden are the aboral small intestine and colon [44]. 
Histologically, disease is characterized by a neutrophilic exudate, disruption of 
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the epithelial cell layer, submucosal edema, and villous blunting [45, 46]. Each of 
these features of clinical disease is similar to those observed in human disease. 
 Numerous bovine infection models have been described with variation in 
the age of animals and route or duration of infection. Oral infection models have 
the benefit of recapitulating the natural route of infection and allow monitoring of 
the host response for the duration of infection as well as evaluation of efficacy of 
vaccination or treatment for modulation of disease. Calves are most susceptible 
to development of enteric disease between 3 and 8 weeks of age and the 
proportion of animals that develop diarrhea increases with infectious dose [43]. 
Most animals 3 to 8 weeks of age will develop diarrhea if given an oral dose of at 
least 1010 colony forming units (CFU). Calves younger than 3 weeks of age 
commonly develop bacteremia upon oral infection with non-typhoidal serotypes, 
making younger animals poor models for the study of enteric disease 
pathogenesis. The limitations of the calf oral infection model include obvious 
animal welfare concerns as the animals develop diarrheal disease, the relatively 
large cost of animal purchase and housing, and the relative inconsistency in 
disease development unless large infectious doses are delivered.   
 Surgical models of infection have proven useful to study Salmonella 
factors necessary for colonization of the intestine as well as the early response 
of the epithelium to Salmonella. The calf is particularly well suited for surgical 
models because bovine Peyer’s patches are diffuse and extend the entire length 
of the ileum and aboral portion of the jejunum, making more than 1 meter of 
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intestine available to study colonization and epithelial response to infection. Both 
short- (up to 12 hours) and long-term (5 days) models have been described [45-
47]. In the short-term ligated ileal loop model, 109 organisms are injected directly 
into the lumen of ligated intestinal segments in anesthetized calves (reviewed in 
[48-50]). Detailed kinetic studies have revealed STm invasion of the epithelial 
layer beginning within 5 minutes of infection and neutrophil influx beginning 
within 15 minutes of infection [45, 46]. By 8 to 12 hours post-infection, the 
mucosal surface is denuded and a pseudomembrane forms, similar to the 
pathology in natural infection [42]. The volume of fluid accumulation within the 
lumen is correlated with the neutrophilic inflammatory response (Figure 1.2 and 
reference [51]) reducing the necessity for histologic evaluation of each loop to 
determine host response. The host response has been cataloged for infection 
with both wild-type organisms and mutants lacking the TTSS-1 [52] laying the 
groundwork for further interrogation of the host response in this model. 
 Calf models have made great contributions to the knowledge of 
Salmonella pathogenesis. First, as a natural host for Salmonella, calves develop 
disease with similar clinical course and histologic abnormalities observed in 
people infected with NTS. Second, calf models allow hypothesis testing in an 
outbred population, with all of the potential genetic variation that exists in nature. 
Finally, the study of enteric disease in calves allows for development of 
interventions that may be useful for both cattle and humans to reduce the  
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incidence of disease globally. The short-term ligated ileal loop model has the 
benefit of allowing for up to 35 experiments in a single animal, thereby reducing 
the intra-animal variation in disease response observed in an outbred 
population. Additionally, calves are anesthetized for the duration of the 
experiment and therefore do not experience the discomfort associated with 
enteric disease and development of endotoxemia. However, ligated ileal loops 
are considered isolated compartments, precluding the evaluation of the effects 
Figure 1.2: Fluid accumulation in calf ligated ileal loops correlates with the 
inflammatory response. (A) In situ ileal loop 12 hours post-infection with 109 CFU 
virulent Salmonella Typhimurium filled with inflammatory fluid and (B) pseudomembrane 
covering the epithelial surface of ileal tissue. (C) In situ ileal loop infected with an 
avirulent STm mutant lacking the type-3 secretion system-1 (∆SPI-1) with very little fluid 
accumulation and (D) normal appearance of the epithelial surface. (E) The volume of 
fluid that accumulates in loops infected with virulent WT STm is significantly greater 
than that of loops infected with an avirulent mutant (∆SPI-1), those inoculated with 
sterile media alone, or uninoculated loops. * P < 0.05 using Student’s t-test. 
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of progressive motility of ingesta and microbes on Salmonella colonization. 
Additionally, this model requires highly trained investigators with surgical 
expertise, a surgical suite large enough to accommodate a 50-kg animal, and 
trained staff to monitor the animal during the anesthetic period. Calves are 
expensive as compared with conventional laboratory animals and require 
specialized housing prior to the experiment. Finally, as natural hosts of the 
organism, cows may shed Salmonella subclinically, acting as a potential source 
of infection of calves. Thus, it is essential to ensure the animal has not been 
exposed to Salmonella prior to the experiment. In spite of these shortcomings, 
the calf surgical model has undeniable power in the study of the early stages of 
intestinal colonization, a stage of infection that has been under-interrogated and 
has great potential for discovery. 
   
Mechanisms of Salmonella colonization of the host 
 Huge advances have been made in recent decades to elucidate the 
virulence mechanisms of Salmonella using various animal models. Salmonellae 
gain entry into the host through ingestion and must rapidly respond to a wide 
variety of environmental conditions in the digestive tract: acidic pH in the 
stomach, bile salts within the small intestine, host-derived antimicrobial peptides, 
and high osmolarity of luminal fluid (reviewed in [53]). In addition, Salmonella 
must compete with the host and resident microflora for continuously changing 
nutrient sources. Once within the intestinal lumen, motility mediated through 
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peritrichous flagella, is critical for contact with the epithelium and virulence of the 
organism [54-57].  
 
Anaerobic metabolism and gut colonization 
 The intestine is a specialized and highly diverse niche. Oxygen tensions 
in the lumen decline from the stomach to the colon [58, 59]. In addition, there is 
an increasing gradient of oxygen tension from the center of the lumen towards 
the epithelium [60]. Salmonella must replicate within these anaerobic conditions 
and begin expression of virulence programs including the type-3 secretion 
system-1 (TTSS-1). Shigella flexneri, a related enteric pathogen, uses the 
oxygen gradient within the intestinal lumen to induce the expression of a 
functional TTSS in order to invade the intestinal mucosa directly linking virulence 
to oxygen sensing [61].  
 As facultative anaerobes, Salmonella and E. coli share the core metabolic 
pathways for anaerobic lifestyle: nitrate and fumarate respiration and 
fermentation [62]. The transcriptional and protein profiles of anaerobically-grown 
Salmonella mutants deficient in fnr and arcA, the two known master regulators of 
anaerobic metabolism, have already been established [63-65]. One striking 
difference in the fnr-dependent transcriptome between Salmonella and E. coli is 
the fnr-dependent regulation of the Salmonella TTSS-1 and other virulence 
genes absent in E. coli [64, 66]. These important findings suggest that anaerobic 
gene expression has evolved since Salmonella diverged from E. coli and that 
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further mechanistic study of Salmonella in anaerobic conditions is essential to 
understand the behavior of this pathogen in the intestine. 
 
Exploitation of the host response 
 Salmonella senses environmental cues such as osmolarity of luminal fluid 
[67, 68], composition and concentration of microbial-derived short chain fatty 
acids [69-71], oxygen tension [67, 72, 73], and likely many other signals to 
induce the expression of the TTSS-1 encoded within Salmonella pathogenicity 
island-1 (SPI-1). Through this system, protein effectors are injected directly into 
the host cell cytosol in order to induce uptake of the organism [47, 51, 74-79]. An 
alternate TTSS-1 independent mechanism of crossing the epithelial barrier is 
through dendritic cell luminal sampling [75, 80]. The key to successful infection 
is passage across the epithelial layer, a process that also requires the TTSS-2 
[33, 47, 81] in order to access the lamina propria and induce a strong host 
inflammatory response.  
 Pro-inflammatory cytokines and chemokines are induced in response to 
the TTSS-1 during infection that result in neutrophil trafficking to the intestine 
(reviewed in [82]). Bovine neutrophils release a wide array of compounds 
including but not limited to reactive oxygen species (ROS; superoxide anion   
[O2-], hydrogen peroxide [H2O2], hypochlorous acid [HOCl], and chloramines), β-
defensins, serine proteases, metalloproteinases (collagenase and gelatinase), 
cathelicidins, and calprotectin when activated [83, 84]. Salmonella encounters 
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neutrophil-derived antimicrobial products both within the lumen of the intestine 
and during transient residence within neutrophils [85]. However, it is relatively 
resistant to the toxic byproducts of neutrophils through a variety of mechanisms 
including resistance to ROS and antimicrobial peptides (reviewed in [86, 87]).  
 The host inflammatory response gives Salmonella a competitive 
advantage over resident microflora. Within the intestinal lumen, the product of 
the neutrophilic oxidative burst generates tetrathionate from oxidation of 
thiosulfate [88]. Salmonella uses tetrathionate as a terminal electron acceptor 
within the anaerobic conditions of the intestinal lumen to gain a competitive 
advantage over resident microflora. Effectors of the TTSS-1 may directly 
activate epithelial production of inducible nitric oxide synthase (iNOS) thereby 
creating nitrate, an additional terminal electron acceptor [76]. The relative 
importance of nitrate during infection is illustrated by the fact that it is a powerful 
chemoattractant for Salmonella during anaerobiosis [89]. In addition, Salmonella 
uses host-derived nutrients such as ethanolamine [90], microbial-liberated host-
derived nutrients such as 1,2-propanediol [91], and is capable of scavenging 
transition metals zinc and iron [92-94] during intestinal inflammation. It is clear 
that NTS have developed numerous mechanisms to benefit from the host 
inflammatory response in order to gain a competitive advantage within the 
complex microbial niche of the intestinal tract.    
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Genetic screens to identify novel mechanisms to colonize animal hosts 
 Despite many eloquent studies describing virulence mechanisms of 
Salmonella, the number of cases of human enteric salmonellosis has remained 
unchanged for more than 15 years [95]. This fact as well as the emergence of 
MDR salmonellae drives the need for further studies to elucidate the 
mechanisms used by this bacterium to survive within different niches in the host. 
Genetic screens are invaluable resources used for decades to understand the 
biology of bacteria and other organisms. Invaluable information can be gleaned 
from well-designed genetic screens. For example, the regulation of the lactose 
and maltose operons were described as a result of meticulous, well-designed 
screens and the regulation of these operons have become paradigms for 
bacterial gene regulation upon which large volumes of data have been based 
(reviewed in [96]).  
 By far the majority of genetic screens have been completed in mouse 
models of infection, primarily using Salmonella-sensitive mice lacking the 
NRAMP-1 gene [97-103]. This has resulted in a wealth of knowledge on 
Salmonella pathogenesis but the murine response to enteric infection with 
Salmonella is a poor representation of enteric salmonellosis in natural hosts. 
Recently genetic screens using animals that are natural hosts of the organism 
have been published [104-107]. These studies have served two major purposes. 
First, they have highlighted the obvious fact the genes necessary for systemic 
colonization differ from those for enteric colonization. Second, they show that 
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Salmonella has evolved numerous mechanisms for colonization of different 
hosts that are most likely related to the biology of the host organism. These 
studies illuminate the importance of studying disease in a natural host in order to 
interrogate the mechanisms needed by the pathogen to colonize the host 
organism. Using a calf model of infection, we show two novel mechanisms of 
colonization of the intestine: production of a hybrid RNA-DNA molecule called 
multicopy single-stranded DNA and phosphonate utilization.  
 
Retron reverse transcriptases 
 The reverse transcriptase, an enzyme that transfers genetic information 
from RNA to DNA, was first described in 1970 by David Baltimore and Howard 
Temin in retroviruses [108, 109]. Bacterial reverse transcriptases were first 
identified in 1984 in Myxococcus xanthus [110]. Investigators consistently found 
a fast-migrating band of nucleic acid during isolation of genomic DNA that they 
named multicopy single-stranded DNA (msDNA). A gene encoding a reverse 
transcriptase neighbored the sequence of msDNA and msDNA was a covalently 
linked hybrid RNA-DNA molecule (Figure 1.3). The operon containing the 
sequence of msDNA and the reverse transcriptase was termed a ‘retron.’ 
Further work showed that a clinical isolate of E. coli produced msDNA [111] and 
since that time numerous species of eubacteria and archaea have been found to 
produce these molecules [112-128]. Salmonella Typhimurium encodes a reverse 
transcriptase and produces msDNA [112, 122, 129, 130]. 
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 All retrons contain three essential components for the production of 
msDNA: msr (RNA primer), msd (template sequence for reverse transcription) 
and the reverse transcriptase [117]. Retrons of pathogens may also encode an 
additional open reading frame of unknown function [112]. There has been 
extensive study of the mechanism of msDNA production (reviewed in [117]). The 
operon is transcribed from a single promoter and a series of inverted repeats 
located both within the sequence of msd and located 5’ to msr and 3’ to msd 
allow the transcript to fold on itself. This temporary structure places a guanine 
residue of msr (present in all msDNAs) in contact with the sequence of msd. 
This guanine is the priming residue whereby the reverse transcriptase adds an 
Figure 1.3: Predicted secondary structure of msDNA St-85 from STm. RNA 
component is shown in green and DNA component in black. The RNA and DNA portions 
are covalently linked by a 2’ 5’ phosphodiester linkage at a guanine encoded by msr. 
Figure adapted from [112]. 
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msd sequence-specific deoxyribonucleotide to the 2’ hydroxyl group to create a 
2’ 5’ phosphodiester bond between the guanine and incoming DNA [131]. It is an 
absolute requirement that the sequence of msr and the reverse transcriptase 
originate from the same retron [132]; however the possibility that additional 
mRNAs sharing the sequence of msr can be turned into cDNA has been 
suggested [133]. There are specific residues and structures within msr that are 
required for the production of msDNA [134]. For production of a mature msDNA, 
RNase H is required to remove the RNA encoded by msd [135] and it is possible 
to produce msDNA in vitro with purified msr/msd transcript, reverse 
transcriptase, and RNase HI [136]. It has been reported that some mature 
msDNA are missing the RNA-portion encoded by msr [112, 114, 121, 122], 
although the available data are not convincing in all cases. Despite the detailed 
information on the mechanism of msDNA production, the function of this 
molecule remains elusive. 
 The lack of an observed phenotype in mutants unable to make msDNA 
has been a major roadblock to elucidating the function of this unique molecule. 
Two hypotheses of function have been explored using artificial systems. One 
hypothesis was that msDNA with mismatched base pairs in the msd-encoded 
stem increases the rate of mutation of the host bacterium through sequestration 
of mismatch repair proteins [137-139]. The other hypothesis is that msDNA acts 
in a regulatory fashion through an unknown mechanism [140, 141]. In all 
published studies, msDNA from one organism or strain was highly over-
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expressed in a heterologous organism or strain that lacks msDNA. Thus, it is not 
possible to determine whether the results indicate the natural function of the 
molecule or result from massive (>10,000 fold) over-expression of a foreign 
nucleic acid species. Therefore, the natural function of this molecule remains 
elusive, despite intensive study over a period of 30 years. 
 
Phosphorus homeostasis within the microbial community 
 Salmonellae live within microbial communities during all stages of life, 
whether within the intestine of an animal host or within the soil or bodies of 
water. In order to replicate within these communities, salmonellae are capable of 
withstanding microbial-derived antimicrobial products and have strategies for 
gaining nutrients within these diverse environments. Numerous strategies such 
as host cell invasion, benefitting from the products of the host inflammatory 
response, and preferential utilization of nutrients have already been discussed.  
 One under-studied aspect of Salmonella metabolism in the host is 
phosphorus acquisition and utilization. Phosphate anion (PO42-; Pi) is important 
for numerous cellular processes including signal transduction, energy 
production, gene regulation, and many more. The phosphorus content in the 
intestinal lumen varies with diet, location, and species [142]. The majority of 
intestinal phosphate is absorbed in the small intestine of monogastrics [143, 
144] and ruminants [145], although the actual location along the small intestine 
differs between species. Hindgut fermenters also absorb phosphate in the small 
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intestine but also secrete phosphorus into the large colon, likely to serve as a 
buffer in this environment [146]. These data suggest that there are locations 
within the host infestinal tract where phosphorus will be in limited supply and that 
these locations will likely differ between host species. 
 In E. coli, phosphorus homeostasis is regulated by the two-component 
regulatory system PhoBR (reviewed in [147]), where PhoR is the sensor and 
PhoB the transcriptional regulator. During phosphorus starvation (<4 µM Pi), 
PhoR phosphorylates PhoB to induce expression of genes of the Pho regulon. 
The Pho regulon contributes to virulence mechanisms in both 
enterohemorrhagic E. coli [148] and Salmonella [149], although the relative 
importance of this regulon in the metabolism of Salmonella within the intestine of 
the host has not been explored. 
 One method some microorganisms employ to survive in the face of 
phosphorus limitation is to produce phosphonates, molecules characterized by 
stable carbon-phosphorus bonds. The relative importance of phosphonates has 
been best characterized in marine ecosystems where Pi is limiting and 
phosphonates contribute approximately 25% to the total organic phosphorus 
content of oceans [150]. Bacteria and some marine invertebrates produce 
phosphonates to store phosphorus [151, 152]. In addition to a metabolic utility of 
these molecules, some of these compounds have potent antimicrobial activity 
[153, 154] and may be produced by microbes for interspecies competition.  
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 With only one known exception, the synthesis of all phosphonates begins 
with the same initial steps [154]. The carbon-phosphorus bond is produced from 
phosphoenolpyruvate by the action of the coupled enzymes 
phosphoenolpyruvate phosphomutase (PepM) and phosphonopyruvate 
decarboxylase (Ppd) to generate phosphonoacetaldehyde, which is converted to 
2-aminoethylphosphonate (2-AEP) by AEP transaminase [151, 154]. 2-AEP was 
the first phosphonate to be identified and was found in the sheep rumen [155]. 
The concentration of 2-AEP in ruminal and duodenal contents was higher in 
sheep with undisturbed microflora as compared with defaunated sheep [156]. 2-
AEP has been identified in feed as well as various tissues from mammals [156-
158]. Mammals lack genes necessary for biosynthesis of 2-AEP so it has been 
hypothesized that they utilize phosphonates from dietary sources [154]. The 
genes for biosynthesis and utilization of various phosphonates have been 
identified in many phyla of eubacteria and archaea, including γ-proteobacteria, 
isolated from diverse sources including animal sources [151, 152, 159].  
 Although Salmonella lacks genes for the biosynthesis of phosphonates, it 
has the capability to utilize these compounds and at least one of the loci (for 2-
AEP utilization) is under control of the Pho regulon [160, 161]. Phosphonates 
are present within the intestine and in other locations within animal hosts and 
Salmonella may encounter these molecules during infection. However, no 
studies to date have elucidated the role of phosphonates in the virulence 
strategies of Salmonella or its metabolic profile during infection of a host. 
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Conclusion 
 Approximately half of the genome of Salmonella Typhimurium is of 
putative function or unknown function [129]. This organism undoubtedly 
possesses strategies for colonization of the intestine that have yet to be 
described. The following chapters will describe my work to identify new genes 
needed for Salmonella Typhimurium to colonize the intestine. In chapter 2, a 
genetic screen performed using the calf ligated ileal loop model is described. In 
chapter 3, a study to identify the function of multicopy single-stranded DNA is 
described. Finally, in chapter 4, the relationship of a transcriptional regulator 
needed for colonization of the intestine with phosphonate metabolism is 
described. Each of these newly described strategies for intestinal colonization 
were identified during infection of a natural host and each represent new targets 
for development of vaccine or antimicrobial strategies, critically needed to 
combat the global Salmonella burden. 
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CHAPTER II 
NOVEL DETERMINANTS OF INTESTINAL COLONIZATION OF SALMONELLA 
ENTERICA SEROTYPE TYPHIMURIUM IDENTIFIED IN BOVINE ENTERIC 
INFECTION* 
 
Overview 
 Cattle are naturally infected with Salmonella enterica serotype 
Typhimurium and exhibit pathologic features of enteric salmonellosis that closely 
resemble those in humans. Cattle are the most relevant model of gastrointestinal 
disease resulting from non-typhoidal Salmonella infection in an animal with an 
intact microbiota. We utilized this model to screen a library of targeted single 
deletion mutants to identify novel genes of Salmonella Typhimurium required for 
survival during enteric infection. Fifty-four candidate mutants were strongly 
selected, including numerous genes known to be important for gastrointestinal 
survival of salmonellae. Three mutants with previously unproven phenotypes in 
gastrointestinal infection were tested in bovine ligated ileal loops. Two of these 
mutants, in STM3602 and STM3846, recapitulated the phenotype observed in 
                                                 
* Reprinted with permission from “Novel determinants of intestinal colonization of 
Salmonella enterica serotype Typhimurium identified in bovine enteric infection” by 
Johanna R. Elfenbein, Tiana Endicott-Yazdani, Steffen Porwollik, Lydia M. 
Bogomolnaya, Pui Cheng, Jinbai Guo, Yi Zheng, Hee-Jeong Yang, Marissa 
Talamantes, Christine Shields, Aimee Maple, Yury Ragoza, Kimberly DeAtley, Tyler 
Tatsch, Ping Cui, Katharine D. Andrews, Michael McClelland, Sara D. Lawhon, and 
Helene Andrews-Polymenis, 2013. Infection and Immunity, Volume 81, Pages 4311-20, 
Copyright © 2013 American Society for Microbiology. 
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the mutant pool. Complementation experiments successfully reversed the 
observed phenotypes, directly linking these genes to the colonization defects of 
the corresponding mutants. STM3602 is a putative transcriptional regulator that 
may be involved in phosphonate utilization and STM3846 is a retron reverse 
transcriptase that produces a unique RNA-DNA hybrid molecule called multicopy 
single-stranded DNA. The genes identified in this study represent an exciting 
new class of virulence determinants for further mechanistic study to elucidate 
the strategies employed by Salmonella to survive within the small intestine of 
cattle. 
 
Introduction 
Non-typhoidal salmonellae (NTS) are the leading cause of bacterial 
foodborne gastroenteritis in people worldwide [1, 2], and are responsible for 
hundreds of millions of cases of gastroenteritis and bacteremia annually [5]. In 
humans, gastrointestinal disease caused by NTS is characterized by neutrophilic 
infiltrates within the ileum and symptoms of inflammatory diarrhea [6].  
Cattle are naturally susceptible to infection with NTS and develop 
inflammatory diarrhea histologically characterized by neutrophilic inflammation 
[46, 48]. Cattle either clear the organism after resolution of disease or become 
persistently infected and continually shed Salmonella in the feces [162]. 
Approximately 30% of human cases of enteric salmonellosis originate from 
bovine sources [24]. Therefore, knowledge of factors important for survival of 
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Salmonella within the gastrointestinal tract of cattle allows not only extrapolation 
to human disease, but also the opportunity for creation of new strategies to 
reduce bovine colonization and thus reduce the contamination to the food supply 
and environment.  Additionally, use of calves as a model organism makes 
discoveries in this model directly applicable to farm animal populations.  
Although there are many tractable animal models of salmonellosis, the 
majority of screening and the development of mechanistic understanding of NTS 
infection have historically been done in small animal models that do not naturally 
develop inflammatory diarrhea upon infection with NTS. These models include 
mice of the BALB/c, C57B6, 129SvJ, and CBA/J lineages [49, 98, 103]. To more 
closely resemble human disease, mice can be treated with antimicrobials to 
eliminate natural microflora prior to infection with Salmonella. These pre-treated 
animals do develop neutrophilic inflammation (commonly known as the murine 
colitis model) [28, 30, 31, 38]. The murine colitis model is attractive because it 
requires minimal technical expertise and allows study of host factors involved in 
Salmonella pathogenesis through use of widely available immunological 
reagents and genetically altered mice. However, the lack of an intact microbiota 
precludes full evaluation of the strategies used by Salmonella to survive in the 
complex microbial ecosystem of the gastrointestinal tract. Thus the use of an 
animal that is a natural host of Salmonella is optimal to understand the biology of 
Salmonella during infection. 
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The current animal model with intact microbiota that most closely 
resembles gastrointestinal salmonellosis in people in both clinical presentation 
and histopathology is the calf model of infection [45, 48, 79]. This model, 
although expensive and complex to use, has become very useful for 
identification of bacterial factors necessary for NTS to thrive in the complex 
environment of the gastrointestinal tract [51, 57, 88, 163]. Bovine ligated ileal 
loops have been used to elucidate the absolute requirement of the type III 
secretion system (TTSS) and effectors encoded by Salmonella pathogenicity 
island-1 (SPI-1) for development of neutrophilic enteritis [46, 51, 52, 79]. They 
have also been used to study the importance of flagella for virulence [57], and to 
understand the mechanism by which Salmonella employs the host inflammatory 
response to gain a survival advantage by the use of tetrathionate as a terminal 
electron acceptor [88]. An additional benefit of the calf model is that it reliably 
replicates enteric salmonellosis in cattle, a population that contributes to the 
maintenance of Salmonella in the food supply and environment, allowing for 
development of novel pre-harvest interventions for this important zoonotic 
pathogen [44, 48-50, 164]. However, because of its complexity this model has 
not previously been used in an unbiased approach to study novel virulence 
factors. 
Ligated ileal loops in calves provide a unique environment for the study of 
Salmonella pathogenesis where virulence factors necessary for establishing 
early infection may be identified in the presence of intact microbiota. We 
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previously constructed a library of targeted single gene deletion (SGD) mutants 
of Salmonella Typhimurium that we used to discover novel genes required for 
survival during systemic infection in BALB/c mice [97]. In the work described 
here, we used this library of targeted single gene deletions in combination with 
the calf ligated ileal loop model to identify novel genes used by Salmonella 
during enteric infection of a natural host. Using this strategy, we identified 54 
mutants under selection. Over 20 of these genes have not previously been 
described as under selection in this model. We tested three mutants (in 
STM3602, STM3846, and STM4602) and confirmed two in individual competitive 
infections, in addition to testing and confirming ΔphoP and ΔphoQ mutants (for a 
total of 5 mutants tested). Complementation in trans restored the ability of 
mutants in STM3602 and STM3846 to colonize ligated ileal loops. The genes we 
reveal here to have roles in colonization represent an exciting group for further 
study to elucidate the mechanisms that Salmonella use to survive within and 
cause disease in the complex environment of the small intestine of cattle. 
 
Methods 
Ethics ?tatement 
The Texas A&M University Institutional Animal Care and Use Committee 
approved all animal experiments, and all experiments were performed in 
accordance with the PHS "Guide for the Care and Use of Laboratory Animals", 
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and USDA Animal Welfare Regulations. Texas A&M has AALAC accredited 
animal facilities.  
 
Bacterial strains 
 All bacterial strains are isogenic derivatives of virulent Salmonella 
enterica serotype Typhimurium ATCC14028. The SGD mutant library was 
constructed as previously described [97]. All bacteria were grown in Luria 
Bertani (LB) broth or LB agar supplemented with kanamycin (50 mg/L), nalidixic 
acid (50 mg/L), carbenicillin (100 mg/L), or streptomycin (100 mg/L) where 
appropriate.  
 
Construction of complementing plasmids 
 PCR products were generated by colony PCR using Pfu polymerase 
(Agilent Technologies). To obtain a 1.1 kb PCR product for STM3602 we used 
an annealing temperature of 45˚C for 5 cycles, 58˚C for a further 25 cycles, and 
the following primers: 3602forward 5' GTTGAATTCTTCCGCCTCGATCATTTC 
3' and 3602reverse 5' GTCAAGCTTTCATACGGTAAACCGTATTTTATC 3'. To 
clone STM3846, a PCR reaction using an annealing temperature of 45˚C for 5 
cycles, and 57˚C for a further 25 cycles, generated a 1.7 kb product using the 
following primers: 3846forward 5' 
GTCGAATTCAAGTCTCATCCTCTGTTGTAATCTATC 3' and 3846reverse 5' 
GTCAAGCTTTATCTACAGCGTTCTGTCTGC 3'. The appropriate length of the 
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PCR products was ensured by agarose gel electrophoresis. A poly-A tail was 
added to the 3’ end of the product using Taq polymerase (New England Biolabs) 
for 9 minutes at 72˚C. PCR products were then ligated into pCR2.1 (TOPO TA 
cloning; Invitrogen) and transformed into chemically competent One Shot E. coli 
(Invitrogen) using heat shock, following manufacturer’s instructions. Plasmids 
were isolated using the Qiagen Miniprep kit (Qiagen), and the insert was 
removed by digestion with EcoRI (New England Biolabs). The insert was 
isolated from the plasmid backbone by agarose gel electrophoresis and gel 
purified using a Qiaquick gel purification kit (Qiagen). The insert was then ligated 
into EcoRI digested and gel purified pWSK29 [165]. Ligations were performed 
overnight at 14oC, using T4 DNA ligase (New England Biolabs). Ligation 
reactions were transformed into chemically competent E. coli XL-1 blue 
(pSTM3846) or Mach One E. coli (pSTM3602, Invitrogen). Transformants were 
obtained by selection on LB agar supplemented with carbenicillin, and were 
streaked twice to single colonies. Plasmids were isolated using the Qiagen 
miniprep kit (Qiagen), and correct inserts were verified by restriction digestion of 
plasmids using BamHI or BstXI (New England Biolabs; pSTM3846 and 
pSTM3602, respectively). The desired sequence was confirmed by sequencing. 
Complementing plasmids were transformed into chemically competent S. 
Typhimurium LB5000 (restriction -, modification +) [166], and transformants 
were obtained by selection on LB with carbenicillin. Plasmids were then isolated 
as above and transformed into ∆STM3846 and ∆STM3602 mutants using heat 
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shock or electroporation, respectively. Mutants bearing complementing plasmids 
were purified by streaking twice for single colonies prior to use in competitive 
infection experiments. 
 
Calves and ligated ileal loop surgery 
 Angus-cross calves were obtained from a breeding herd at the Veterinary 
Medical Park at Texas A&M University. A total of 12 calves were used in this 
study; three for screening the mutant library and 9 for competitive infection and 
complementation analysis. Calves were separated from the dam at 1 day of age 
and adequate passive transfer estimated by measurement of serum total 
protein. Calves were housed in an AALAC approved barn, fed milk replacer 
twice daily and were provided with free choice water and grass hay. Selective 
fecal cultures were performed at least once weekly to ensure calves remained 
negative for Salmonella spp. [46, 167]. 
 At 3-6 weeks of age, calves were anesthetized for ligated ileal loop 
surgery as previously described [45, 46]. Briefly, calves were placed in left 
lateral recumbency and a right flank incision was made. Twenty-four to thirty 
eight 4-6 cm loops were tied within the ileum within grossly visible Peyer’s 
patches, leaving 1 cm spacers between adjacent loops. Loops were infected 
individually with 3 mL of LB containing approximately 109 Salmonella 
Typhimurium. The intestine was returned to the abdomen, the incision closed, 
and the calves were monitored under inhalant anesthesia for the duration of the 
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experiment. At 12 hours post-infection the incision was opened and each loop 
individually excised. Calves were euthanized by barbiturate overdose 
(pentobarbital) administered intravenously.  
 
SGD pool preparation, inoculation and recovery from ligated ileal loops 
The pool of ~1000 SGD mutants prepared and described previously [97], 
was grown overnight at 37˚C with agitation in LB supplemented with kanamycin. 
Overnight cultures were subcultured 1:100 into LB with kanamycin and 
incubated for 3 hours at 37˚C with agitation. Cultures were washed twice in 
sterile LB broth, and the concentration of organisms was adjusted to 109 CFU in 
3 mL LB. A wild type strain marked with streptomycin resistance in a neutral 
location, HA697 (ΔphoN::strep) [168], was added at a ratio of 1:500 (HA697:total 
inoculum) to measure random loss of mutants in the pool. Eight ligated ileal 
loops were inoculated with the SGD library in 3 total calves. Inoculum titers were 
determined by serial dilution and plating. Following excision of the infected 
loops, intestinal fluid, mucus, and tissue were harvested and processed 
separately. Fluid volume, which is correlated with inflammatory response [51], 
was calculated by weighing each loop before and after removal of fluid. Data 
from only those loops with similar fluid accumulation to a WT-infected control 
loop were used. Mucus was gently scraped from the epithelial surface and 
diluted in 3 mL PBS. The remaining tissue was diluted in 5 mL PBS. These 
specimens were subsequently homogenized and were serially diluted in PBS 
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and plated for enumeration of CFU. The remaining homogenates were grown to 
stationary phase in LB supplemented with kanamycin and washed in PBS prior 
to extraction of total DNA.  
 Mutants with an observed phenotype during the library screen were 
selected for competitive infection experiments against the wild type (WT), HA420 
(ATCC 14028 NalR). Mutations were moved into a clean genetic background 
using P22 transduction [169]. Mutant strains and the isogenic WT were grown in 
LB with kanamycin and nalidixic acid (mutant) or with nalidixic acid alone (WT) 
as described above. The inoculum was prepared by mixing SGD mutant and WT 
at a 1:1 ratio. Ligated ileal loops from 3 to 8 calves were infected with the 
prepared inoculum and the WT to mutant ratio of the inoculum was determined 
by serial dilutions and plating. Intestinal fluid, mucus, and tissue were processed 
as described above and the ratio of WT to mutant determined by differential 
plating. Competitive index (CI) was determined by dividing the output ratio of WT 
to mutant by the inoculum ratio. 
 
Microarray analysis  
 The protocol used to prepare transcripts from input and output pools for 
microarray analysis was essentially as previously described [97]. Briefly, total 
DNA of input or output mutant pools was sonicated, poly-A tailed, and PCR 
amplified with a primer targeting the shared portion of each mutant and a primer 
including oligo dT at the 3’ end [97]. PCR products were subjected to reverse 
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transcription from a T7 RNA polymerase promoter located inside each mutant 
and a mixture of NTPs that included a fluorescently labeled UTP. The RNA was 
purified using the RNeasy Mini Kit (Qiagen), and approximately 4 micrograms of 
labeled RNA was hybridized to a NimbleGen tiling array of 387,000 50-mer 
oligonucleotides at 42°C for 16 hours. The arrays were washed according to the 
manufacturer’s protocol, and scanned using a GenePix 4000B laser scanner 
(Molecular Devices, Sunnyvale, California) at 5 µm resolution. Data was 
uploaded into WebArrayDB [170-172] and data analyzed for peak height in the 
DNA directly downstream of each mutant location. The relative signal of each 
mutant was compared to the relative signal in a corresponding array of the same 
library prior to selection. All large changes in mutant representation were 
manually inspected and converted into a numerical score between -1 (strongly 
under-represented in the output pool) and 1 (over-represented in the output 
pool).      
 
Data analysis 
 The SGD library was screened in a total of 8 loops: four in one calf, and 
two loops each in two further calves. A mean score for mutants in each calf was 
determined by calculating the mean score from multiple loops. The overall score 
for each mutant was the mean of data from all loops in the 3 calves. Mutants 
that were not represented in the input pool in all of the loops were excluded from 
further analysis. The inter-calf variation was defined as the absolute value of the 
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standard deviation of the mean scores from each calf. Mutants under selection 
in our screen of the SGD library were defined as those mutants with scores 
outside the 90% confidence interval of the mean scores and with an inter-calf 
variation less than the calculated mean score.  
 For competitive infection experiments, the competitive index was defined 
as the ratio of WT to mutant in output normalized to the input ratio. Statistical 
significance was determined using Student’s two-tailed t-test with significance 
set at p < 0.05.  
 
Results 
Screen for mutants under selection during enteritis in calves 
In order to assess the fluctuation of mutant representation in the pool, we 
added a derivative of the wild type marked with streptomycin resistance 
cassette, HA697 (ΔphoN::StrepR), in a neutral location to the input pool [168]. In 
the input pool, HA697 was present in a ratio relative to the total inoculum that 
approximated the representation of each individual mutant in the pool. By 
enumerating the representation of this mutant in the output pool relative to the 
total recovery of the pool, we observed less than 1.4 fold fluctuation of HA697 in 
intestinal tissue samples as compared to the input pool (Figure 2.1). As HA697 
was inoculated into and recovered from loops in approximately the same 
proportion relative to the total pool, there appears to be only minimal random 
loss of mutants occurring during the incubation of our pool in ligated ileal loops. 
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In order to identify candidate mutants under selection in ligated ileal 
loops, both the input pool and the output pool were used to prepare labeled 
transcripts unique to each mutant. Representation of mutants in the input versus 
the output pools was performed by analysis of labeled transcripts using a 
Nimblegen tiling array. The resulting data are presented by genome position of 
each deleted gene represented in the SGD library in Figure 2.2. We identified 54 
mutants under selection in our screen with a mean score outside a 90% 
confidence interval and with an inter-calf variation smaller than the mean (Table 
2.1). We chose to exclude mutants with high inter-calf variation because we 
found numerous mutants with a strong phenotype in only a single calf. These 
Figure 2.1: Mutant representation in the pool remains stable. The ‘input’ pool of 
kanamycin-marked mutants was spiked with HA697 (∆phoN::strep) at a ratio of 1:500 
(HA697:total pool). Comparison of the representation of this mutant in the inoculum to the 
representation of this mutant in the output pools indicated less than 1.4 fold change in 
HA697 representation over the duration of the incubation of the pool in ligated ileal loops.  
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mutants had a mean score outside the 90% confidence interval but are 
considered outliers and not reported here.  
 
 
Figure 2.2: Loss of targeted mutants from the pool after inoculation into ligated ileal 
loops shown by genomic position. 8 ligated ileal loops from 3 different calves were 
infected, collected and analyzed. Scores from multiple loops in a single calf were averaged 
and then an overall mean score was generated from all 3 animals. The X-axis represents 
mutants by genomic position with the mean score plotted on the Y-axis. The horizontal 
dotted lines indicate the 90% confidence interval. Mutants under selection were outside the 
90% confidence interval with an inter-calf standard deviation less than the absolute value of 
the given score. Labeled mutants are in known virulence factors and those that were 
confirmed by individual competitive infection are in black. 
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Table 2.1: Mutants under selection, grouped by pathogenicity island or clusters of 
orthologous groups (COG). Asterisk (*) indicates the mutant was under selection during 
library screen in systemic infection of BALB/c mice [97] and pound (#) [105] or dollar sign ($) 
[104] indicates the mutant was identified during screen of a transposon library in oral 
infection of a single calf. 
 
Gene number Name Gene number Name 
Salmonella pathogenicity island-1 Metabolism 
STM2867* hilC STM0522$ allP 
STM2875#$ hilD STM1636   
STM2883#$ sipD STM2437   
STM2884#$ sipC STM3781   
STM2885$ sipB Signal transduction 
STM2886*#$ sicA STM0398 phoR 
STM2887*$ spaS STM1230*$ phoQ 
STM2888*#$ spaR STM1947* sirA or uvrY 
STM2889$ spaQ STM2958*$ barA 
STM2892$ invJ Transcriptional regulation 
STM2893*$ invI STM0031   
STM2896$ invA STM0552*$ fimW 
STM2897#$ invE STM1588$ yncC 
STM2898 invG STM3245$ tdcA 
Salmonella pathogenicity island-2 STM3602#   
STM1441*# ssaK STM4417*$ iolR 
Salmonella pathogenicity island-4 Unknown 
STM4261#$  STM0278   
Salmonella pathogenicity island-6 STM0285$   
STM0296  STM1258*   
Cell envelope biogenesis STM1329   
STM0719*  STM1331   
STM1737 tonB STM1785   
STM3719*#$ rfaB STM1861   
STM3722*#$ rfaG STM2209   
STM3723*$ rfaQ STM3026   
Cell motility and secretion STM3954 yigG 
STM3975*$ tatC STM4030*   
DNA replication, recombination, repair STM4206$   
STM3846* rrtT STM4302   
Post-translational modification STM4596$   
STM3342$ sspA     
STM4067       
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Among the mutants with reduced fitness, fourteen mutants under 
selection were in genes located in Salmonella pathogenicity island-1 (SPI-1), 
and three were in genes needed for LPS biosynthesis, all known to be important 
virulence determinants of Salmonella during enteric infection [47, 51, 77, 173-
175]. Numerous genes previously identified as virulence factors in animal hosts 
were also identified in our screen: ssaK, a gene within SPI-2 encoding a portion 
of the TTSS apparatus [75, 81]; phoQ, the sensor in the two-component 
regulatory system phoPQ responsible for regulation of virulence genes [176, 
177]; barA and sirA, the sensor and regulator in a two-component regulatory 
system that regulates SPI-1 [69, 178, 179]; tatC, a sec-independent transport 
protein responsible for resistance to bile salts [180]; and tonB, a transport 
protein necessary for iron acquisition in the intestine [181].  
We have already used this library to screen for mutants under selection 
during systemic infection of BALB/c mice [97]. We found nineteen mutants to be 
under selection in both models (Table 2.1). Not surprisingly, of the genes not 
previously implicated to be important in enteric disease, only seven mutants 
were under selection in both models. These results confirm the necessity of 
different genes of Salmonella for survival in different niches during infection and 
show that our library is useful for identification of new virulence factors in 
different animal models.  
  42 
Thirty-one mutants under selection were not previously proven to be 
essential for colonization of the bovine host. Of these genes, six are 
transcriptional regulators, four are involved in metabolism, two each in protein 
modification and cell envelope biogenesis, and one each in DNA modification 
and cell motility and secretion. Sixteen of our new mutants under selection have 
unknown function or are not assigned a group based on clusters of orthologous 
group assignments [182, 183]. Ten of these genes had predicted phenotypes in 
screening of a library of transposon mutants during oral infection of a single calf, 
but no further characterization was performed to validate the results of either 
screen [104, 105]. 
 
Confirmation of fitness defects of candidate mutants in the calf 
 We chose four mutants for confirmation by individual competitive 
infections with a derivative of the isogenic parental wild type ATCC14028. These 
mutants, ∆phoQ, ∆STM3602, ∆STM3846 and ∆STM4206, were transduced to a 
clean genetic background by P22 transduction, and tested in competitive 
infections in ligated ileal loops in at least 3 animals.  
A ∆phoP mutant, although it was just outside the stringent cut-off of our 
screen, was also studied in competitive infection experiments because of its 
known function in resistance against host-derived antimicrobial peptides. We 
determined that the ∆phoP mutant has a statistically significant survival 
disadvantage relative to the wild type organism in ligated ileal loops in calves, as 
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was expected (Figure 2.3). We also confirmed that the ∆phoQ mutant, a 
candidate mutant from our screen, has statistically significant survival defects in 
this model (Figure 2.3).  
 
 
 
 
 
Figure 2.3: Individual competitive infection experiments confirm requirement for 
three genes during infection of ligated ileal loops. Ligated ileal loops were infected with 
a 1:1 mixture of WT and an isogenic mutant, either ∆phoP (n=5), ∆phoQ (HA1501; n=3), 
∆STM3602 (HA1473; n=8), ∆STM3846 (HA1444; n=5), or ∆STM4206 (HA1482; n=4), for 12 
hours. Infected loops were harvested and the fluid contents, mucus layer, and intestinal 
tissue were processed for enumeration of bacteria and determination of competitive index. 
Solid bars indicate the median. (*) Asterisks indicate statistically significant differences 
between the ratio of the mutant and wild type in the inoculum versus in that ratio in the 
material collected at the termination of the infection (‘output’ ratio). Significant difference 
(p<0.05) in the output to input ratio was determined using a two-tailed Student t-test. 
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Using competitive infections we confirmed that deletion of STM3602 and 
STM3846, genes not previously linked to virulence during enteritis, colonize 
poorly during competitive infections in ligated ileal loops (Figure 2.3). It was 
surprising to us that the ∆STM3846 mutant is more severely affected in the calf 
intestine than the mutants in phoP and phoQ, genes with a previously defined 
role in pathogenesis that only have very modest phenotypes in the calf model 
(Figure 2.3).  
We also attempted to confirm the phenotype of a deletion in STM4206 
during competitive infection in 4 calves. Although we were unable to confirm the 
phenotype of this mutant, the calf model has high variability between loops and 
between genetically non-identical animals. Thus we cannot exclude the 
possibility that the predicted phenotype of the ∆STM4206 mutant could be 
confirmed if competitive infection experiments are performed in additional 
animals. To summarize, we were able to confirm the phenotypes of three 
(STM3602, STM3846, and phoQ) of four candidate mutants that met the 
stringent inclusion criteria of our screen, in ligated ileal loops in calves.  
 
Complementation analysis 
 In order to link the observed phenotypes to disrupted genes definitively, 
we chose to complement the two mutants with confirmed phenotypes in trans, 
and re-test these complemented mutants during infection of ligated ileal loops in 
calves.  We cloned STM3602, a putative transcriptional regulator, and 
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STM3846, a putative reverse transcriptase, onto a stable, low copy number 
plasmid and transformed these constructs into the corresponding deletion 
mutants. Complemented deletion mutants were tested in competitive infections 
with the isogenic wild type organism in ligated ileal loops. In both cases, the 
fitness defect of the deletion mutant was reversed by placement of the 
corresponding gene in trans (Figure 2.4).  
 
 
 
 
Figure 2.4: Complementation in trans reverses the observed phenotypes of mutants 
in ∆STM3602 and ∆STM3846. Ligated ileal loops from 5 calves were inoculated with the 
WT and the targeted deletion mutant complemented with an intact copy of the 
corresponding open reading frame in trans (open symbols). Data from the competitive 
infection experiments between WT and targeted deletion mutant (closed symbols), and 
statistical significance (*Figure 2.3) allow direct comparison to complementation data. (A) 
Competitive index for wild type versus the complemented ∆STM3602 mutant. (B) 
Competitive index for wild type versus the complemented ∆STM3846 mutant. In all panels, 
solid bars indicate the median. (**) Double asterisks indicate statistically significant 
differences between the ratio of the mutant and wild type in the inoculum versus in that ratio 
in the material collected at the termination of the infection (‘output’ ratio); (p<0.05) between 
groups as determined by a two-tailed Student t-test. 
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 The genomic contexts of STM3602 and STM3846 are shown in Figure 
2.5 [129, 184]. STM3602 is located between STM3601, a putative phosphosugar 
isomerase, and treF, a trehalase. STM3602 encodes a putative GntR family 
regulator and shares a conserved domain with phnF, a regulator of phosphonate 
utilization [161]. STM3846 encodes a reverse transcriptase that catalyzes the 
formation of an RNA-DNA hybrid molecule called multi-copy single-stranded 
DNA, or msDNA [112, 116, 185].  
 
 
 
 
Figure 2.5: Schematic representation of the genomic regions containing STM3602 
and STM3846 - retron St-85. (A) Schematic diagram of the region surrounding 
STM3602. (B) Schematic diagram of the region surrounding STM3846. This gene is 
located on a 2.13 kb retron at position 4,051,144 on the chromosome between STM3844, 
a pseudogene encoding an integrase with a truncation at amino acid residue 164, and 
yidY, a putative multidrug efflux system protein. The orientations of msr and msd are 
indicated with arrows. Figure adapted from Colibase [184]. 
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Discussion 
 We used a highly relevant model of enteric salmonellosis, bovine ligated 
ileal loops, to identify mutants under selection from our library of targeted 
deletion mutants in Salmonella Typhimurium [97]. Our work is the first example 
of a screen of a mutant library in ligated ileal loops in calves, a technically 
challenging model that is highly relevant to human enteric salmonellosis. In 
addition, this work is the first to confirm predicted phenotypes in the bovine 
model.  
The ligated ileal loop model is ideal for screening of a library of mutants to 
identify the early strategies utilized by Salmonella to survive within the small 
intestinal environment. Using this model, the ‘input’ pool is administered directly 
into the ileum reducing random loss of mutants traveling through the upper 
gastrointestinal tract, and ensuring that all mutants arrive at the small intestine at 
the same time. The short duration of infection allows reliable invasion of the 
epithelium and development of a robust host neutrophilic inflammatory response 
[45, 46]. Thus, we are able study the early factors responsible for survival of 
Salmonella within the lumen of the intestine and those factors necessary for 
creation of and survival during the host inflammatory response. In addition, this 
model provides an opportunity to dissect the genetic strategies required for 
survival in the different microenvironments within the small intestine – intestinal 
fluid, mucus, and tissue layers. 
  48 
 In this study we evaluated the representation of mutants in the output 
pool isolated from intestinal tissue of 3 separate calves because this site might 
include all mutants under selection in the intestinal lumen and mucus layers in 
addition to those mutants defective for invasion or survival within epithelial cells. 
We show that mutants in our pool experience a very low level of random 
fluctuation during infection of loops, removing a significant barrier to screening in 
this model. We screened our mutant library in eight loops in three calves, the 
first screen in any bovine model to use multiple calves to identify candidate 
mutants under selection. We repeated our screen in numerous animals because 
each of our outbred animals may respond to infection differently thus placing 
different selection pressures on our library. To develop a list of candidate 
mutants for further study that had the strongest phenotypes and the highest 
probability of being true positives we used stringent criteria to define a mutant as 
under selection, and this may have excluded some candidate mutants with 
relevant phenotypes from further analysis. One example of a mutant we know to 
be under selection in competitive infection that did not meet our defining criteria 
for significance in our library screen is ∆phoP.   
Only two other screens have been performed in calves [104, 105]. In both 
cases, randomly generated transposon libraries were screened after oral 
infection, and phenotypes were assigned to mutants from infection of a single 
calf. No further characterization of mutant phenotypes was performed in the 
bovine model. Despite the excellent genome coverage obtained by transposon 
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mutagenesis, such studies provide only a list of candidate genes needed in the 
bovine host. They lack an estimated true positive rate of discovery making it 
difficult to determine how many of the candidate genes one would expect to 
have a relevant biological effect in the bovine host. This drawback is a critical 
roadblock to the design of future studies evaluating the importance of candidate 
Salmonella genes in the bovine host, a model that requires specialized housing, 
technical expertise, and great expense as compared with conventional small 
animal models of disease. 
 Fourteen of the fifty-four genes under strong selection in our screen were 
located within SPI-1, and a single gene was located within SPI-2. Among these 
genes were regulators of expression of SPI-1 (hilC and hilD) and proteins 
encoding portions of the TTSS-1 apparatus (sipD, sipC, sipB, sicA, spaS, spaR, 
spaQ, invJ, invI, invA, invE, and invG) [186]. The requirement of the TTSS-1 and 
associated effectors for invasion of epithelial cells and creation of a host 
neutrophilic inflammatory response has been previously described using bovine 
models of enteric disease [47, 51, 77, 173] and has been replicated in the 
murine colitis model [30, 74]. We also predict a phenotype for a single gene 
(ssaK) encoding a portion of the TTSS-2 apparatus. The TTSS-2 and associated 
effectors are necessary for virulence during systemic disease [187] and for 
induction of an inflammatory response in the intestine [47, 188]. However, it is 
possible that 12 hours infection was not long enough to show a more 
pronounced phenotype for the remainder of the SPI-2 genes. These data show 
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that our screen appropriately identifies virulence factors known to be important in 
both bovine and murine models of enteric salmonellosis.  
 Both sirA and barA mutants have predicted phenotypes in the calf model. 
These genes comprise a two-component regulatory system that senses short-
chain fatty acids within the intestine, causing activation of invasion gene 
expression via hilA, the master regulator of SPI-1 [69, 179, 189]. Mutants in 
each of these genes have reduced virulence during oral infection of BALB/c 
mice [69], but have not previously been proven to have a role during enteric 
infection in the bovine host.  
 In order to survive within the gastrointestinal tract, bacteria have 
mechanisms to resist antimicrobial peptides produced by the host. Within the 
small intestine, numerous antimicrobial peptides are constitutively produced by 
Paneth cells and are concentrated in the mucus covering the mucosa [190-192]. 
One response of the mucosa to pro-inflammatory cytokines released as a result 
of Salmonella infection is to increase the production of defensins [193]. 
Polymorphonuclear cells also contain numerous classes of antimicrobial 
peptides within cytoplasmic granules [194, 195]. PhoP and PhoQ comprise a 
two-component regulatory system that responds to antimicrobial peptides to 
regulate genes for LPS biosynthesis and virulence [176, 196-199].  
Therefore, we tested the phenotype of ∆phoQ and ΔphoP mutants in 
competitive infection, even though the latter gene did not meet the stringent cut 
off of our screen. We confirmed the predicted phenotype of our ∆phoQ mutant in 
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intestinal tissue and found that a ∆phoP mutant also has a phenotype in bovine 
ligated ileal loops (Figure 2.3). The ∆phoQ mutant was tested in competitive 
infection in only 3 calves and the lack of an observed phenotype in intestinal 
mucus, the location with the greatest concentration of antimicrobial peptides, 
may be due to small number of calves used in the study. The phenotypes we 
observed for each of these mutants in ligated ileal loops were mild but 
statistically significant (CI of ~2). These mild phenotypes are likely due to the 
short duration of infection or the variable production of antimicrobial peptides as 
a result of the variation in ages of calves used in this study (3-6 weeks). Recent 
reports indicate that 3-week old Holstein-Friesian calves may not constitutively 
express much ß-defensin in the gastrointestinal tract but that this expression 
increases with age [200]. However, it is not known whether antimicrobial peptide 
production in intestinal tissue occurs in response to bacterial infections in calves 
of this age. Our data are the first to directly support the roles of the phoPQ 
regulatory system during survival of Salmonella in the inflamed intestinal tract. 
 STM3602 encodes a putative transcriptional regulator [129], and we show 
that this gene is necessary for survival in fluid, mucus, and tissue in ligated ileal 
loops (Figure 2.3 and 2.4A). STM3602 was predicted to be under selection in a 
signature-tagged mutagenesis screen of transposon mutants during oral 
infection of a calf [105], but the predicted phenotype was never confirmed. This 
gene belongs to the GntR (gluconate operon repressor) family of regulators 
[201] and shares conserved domains with phnF (phosphonate utilization, e-value 
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1.29e-68) [202, 203], the regulator of the phosphonate-utilization operon in E. 
coli [161].  
Phosphonates are stable carbon-phosphorus bonds produced by bacteria 
and some marine invertebrates as a means of storage of phosphate [151, 204]. 
Salmonella Typhimurium has a complete operon containing two genes for 
metabolism of phosphonate (phnVUTSRWX, STM0426-0432, GC content 56-
60%) that is activated by inorganic phosphate during periods of phosphate 
starvation [161] and an additional locus involved in phosphonate metabolism 
(phnOBA, STM4287-4289, GC content 49-55%) [160]. STM3602 is located at a 
different chromosomal site (Figure 2.5A), and has a much lower GC content 
(49.3%) than the phnVUTSRWX operon. Whether STM3602 is involved in 
regulating phosphonate metabolism, and whether this is related to the 
phenotype we observe during enteric infection is not yet clear. STM3602 is a 
very interesting bacterial regulatory protein that merits further study to elucidate 
its precise function during enteric infection.  
 The second deletion mutant that we studied in this work, ∆STM3846, is 
deleted for a putative reverse transcriptase [129]. This gene is encoded on a 
bacterial retro-element termed a retron [112, 116, 124, 185, 205]. Bacterial 
retrons may be both horizontally and vertically acquired and produce a small 
multicopy single-stranded DNA molecule called msDNA, a unique RNA-DNA 
hybrid [124, 185, 205]. STM3846 is encoded on the St-85 retron (Figure 2.5B) 
containing two open reading frames (STM3845 and STM3846) and a small 
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segment of DNA upstream of these open reading frames that encodes the 
primer and the template (msr and msd) used by the reverse transcriptase to 
produce the msDNA [112]. Bacterial reverse transcriptases produce msDNA by 
using a leader RNA encoded by msr to prime the reaction and produce a 2’, 5’ 
phosphodiester linkage between an RNA (encoded by msr) and DNA (encoded 
by msd) molecule [131].  
The msDNA produced by STM3846 is 85 base pairs in length, has a 
predicted stem-loop structure with no mismatched base pairs in the stem [112] 
and may have lost the RNA template [122]. The STM3846 reverse transcriptase 
is present in the genomes of all 19 serotype Typhimurium isolates that we have 
sequenced (McClelland et al., unpublished data). No role for the St-85 retron 
has been established despite several previous studies of genes in this region 
[122, 130]. Furthermore, other entero-virulent Gram-negative organisms, 
including Vibrio spp. and virulent E. coli, produce msDNAs [112] yet no 
phenotypes have been identified for mutants unable to produce any of these 
msDNAs. We are the first to unambiguously show a phenotype for a mutant 
lacking a bacterial reverse transcriptase and this phenotype is for virulence in a 
highly relevant model of disease.  
 In the work we report here, we have used a library of targeted single gene 
deletion mutants to identify novel colonization and virulence determinants of 
Salmonella Typhimurium during infection of bovine ileal loops, a technically 
challenging model highly relevant to human gastrointestinal salmonellosis. The 
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bovine ileal loop model has not previously been used for unbiased screening of 
Salmonella mutants, although it closely replicates early events of enteric 
salmonellosis in humans. We identified more than 30 genes not previously 
proven to be important for survival of Salmonella in this model, and we 
confirmed 3 of these mutants individually in competitive infections. 
Complementation analysis linked the observed phenotypes directly to the 
disrupted genes for mutants in a putative regulator STM3602 and a reverse 
transcriptase STM3846. We show that the reverse transcriptase encoded by 
STM3846 is essential for virulence, and we show the first phenotype of any kind 
for a bacterial reverse transcriptase located on a retron. Finally, we report an 
exciting group of genes for further study to elucidate the mechanisms utilized by 
Salmonella for survival in the complex niche of the host small intestine during 
the inflammatory response. 
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CHAPTER III 
MULTICOPY SINGLE-STRANDED DNA DIRECTS INTESTINAL 
COLONIZATION OF ENTERIC PATHOGENS 
 
Overview 
 Multicopy single-stranded DNAs (msDNAs) are unique hybrid RNA-DNA 
molecules produced by retron reverse transcriptases. Retrons are widespread in 
bacteria but the natural function of msDNA has remained elusive despite 30 
years of study. We report that msDNA of the zoonotic pathogen Salmonella 
Typhimurium is necessary for colonization of the intestine. Similarly, we 
observed a colonization defect in an enteropathogenic E. coli mutant lacking its 
retron reverse transcriptase. Under anaerobic conditions in the absence of 
msDNA, proteins of central anaerobic metabolism needed for colonization of the 
intestine are dysregulated. The msDNA mutant can utilize nitrate but not other 
electron acceptors in anaerobic conditions. Consistent with the availability of 
nitrate in the inflamed gut, a neutrophilic inflammatory response partially rescued 
the ability of a mutant lacking msDNA to colonize the intestine. We conclude that 
regulation of protein abundance is a natural function of msDNA, the first 
attributable function for an msDNA. 
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Introduction 
 Retron reverse transcriptases (RT) in bacteria were first described in 
Myxococcus xanthus [110] and E. coli [111] in the 1980s and are now known to 
be widely distributed in eubacteria and archaea (reviewed in [205]). The product 
of the ‘retron’ is a small covalently linked RNA-DNA hybrid molecule called 
multicopy single-stranded DNA (msDNA) that is predicted to form complex 
secondary structures [114]. msDNA is produced by retrons in many pathogenic 
and non-pathogenic organisms. The predicted secondary structures of msDNAs 
from enteric pathogens are closely related to each other [112] but the reverse 
transcriptase amino acid sequence from these enteric pathogens share little 
identity and the location of the retron as well as the number of retrons in each 
species varies. These observations suggest that retrons have been horizontally 
acquired by convergent evolution to function in a fashion that is specific to the 
biology of the host bacterium. 
All retrons contain three regions essential for production of msDNA: msr 
(RNA primer for reverse transcription), msd (template sequence), and a reverse 
transcriptase (RT). The retrons of pathogens, such as Salmonella Typhimurium 
(STm), may also encode an additional ORF of unknown function [112]. The 
predicted secondary structures of msDNA from enteric pathogens including 
STm, enteropathogenic E. coli and Vibrio spp. are similar [112]. Although the 
molecular details of the production of msDNA have been heavily studied, no 
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natural function is ascribed to this mysterious molecule despite 30 years of study 
(reviewed in [205]). 
 We have shown that the retron reverse transcriptase encoded by 
STM3846 is essential for colonization of the calf intestine [106], a natural model 
of enteric salmonellosis that recapitulates the earliest stages of human non-
typhoidal Salmonella (NTS) infection. NTS are threats to global animal and 
human health and are the most prevalent cause of bacterial food-borne 
gastroenteritis in people in the United States. Enteric salmonellosis is 
characterized by inflammatory diarrhea containing primarily neutrophils. NTS 
use the type 3-secretion system 1 (TTSS-1) encoded on Salmonella 
Pathogenicity Island-1 (SPI-1) to invade the intestinal epithelium [51, 173] and to 
promote the characteristic neutrophilic inflammatory response. Utilization of 
energy sources and alternate electron acceptors produced as a result of this 
neutrophilic influx provide a key competitive advantage to NTS over resident 
microflora [76, 88, 90].  
 In the work described here, we report that mutants lacking msDNA 
produced by the STM3846 reverse transcriptase are defective for colonization of 
the intestine using murine models of salmonellosis. Similar colonization defects 
are observed for an enteropathogenic E. coli lacking its retron reverse 
transcriptase. This colonization defect is due, in part, to a growth defect for these 
mutants in anaerobic conditions. We show that mutants lacking msDNA have 
altered abundance of over 200 proteins in anaerobiosis, many of which are 
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known to be required for growth in anaerobic conditions and pathogenesis of 
STm in enteric infection. Inappropriate abundance of proteins encoding alternate 
terminal electron acceptor reductases results in an inability of mutants lacking 
msDNA to utilize these compounds. The mutants lacking msDNA can only utilize 
nitrate as an anaerobic terminal electron acceptor. Finally, we show that mutants 
lacking msDNA only fail to colonize portions of the intestine lacking neutrophilic 
inflammation, likely due to an ability to utilize nitrate during profound tissue 
inflammation. Thus, we report a role in regulating protein abundance for msDNA, 
the first reported natural function for any msDNA. 
 
Methods 
Bacterial strains  
 All Salmonella strains are derivatives of ATCC 14028s. Enteropathogenic 
E. coli O127:H6 strain E2348/69 [206], a generous gift of M. Donnenberg, is the 
genetic background for EPEC mutants. Mutants were constructed using a 
modification of the lambda-red recombination technique and antibiotic resistance 
cassettes removed as previously described [97, 207]. All Salmonella mutations 
were moved into a clean genetic background by P22 transduction [169]. 
Standard cloning protocols were used to generate complementing plasmids 
[208]. 
  59 
All bacterial cultures were grown at 37˚C aerobically with vigorous 
agitation or standing in an anaerobic chamber with internal atmosphere of 5% 
H2, 5% CO2, and 90% N2 (Bactron I, ShelLab). Alternate electron acceptors 
(Sigma-Aldrich) sodium nitrate, sodium fumarate, sodium thiosulfate, and 
sodium tetrathionate were added to LB to a final concentration of 40mM. Sodium 
chloride (Sigma-Aldrich) at a final concentration of 40 mM served as a negative 
control. DMSO (Sigma-Aldrich) was added to LB to a final concentration of 0.1% 
(v/v). Bacteria were grown in Luria-Bertani (LB) broth or LB or MacConkey 
(Difco) agar supplemented with the following antibiotics as appropriate: 
kanamycin (50 mg/L), nalidixic acid (50 mg/L), carbenicillin (100 mg/L), 
streptomycin (100 mg/L), and chloramphenicol (20 mg/L).  
All experiments were performed on at least three separate occasions. 
Bacterial generation number was calculated using the following equation: 
[log10(CFU final) – log10(CFU start)]/log10(2).  
 
Mouse infections 
 The Texas A&M University Institutional Animal Care and Use Committee 
approved all animal experiments. All experiments that utilized mice were 
performed using 10-12 week old female C57BL/6J mice (Jackson Laboratories). 
For competitive infection experiments, mice were infected by gavage with an 
equivalent ratio of WT and mutant bacteria. The competitive index was 
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determined by dividing the ratio of WT to mutant bacteria in the selected organ 
by that ratio in the inoculum. For single infections, mice were infected with either 
WT or mutant bacteria. The harvested tissue was weighed, homogenized, and 
CFU was determined per gram of tissue collected.  
 Salmonella infections were performed as previously described [28]. For 
the murine colitis model, mice were administered 20 mg streptomycin in 75 µL 
sterile water by gavage. Twenty-four hours after treatment, mice were infected 
with approximately 108 CFU of Salmonella in 100 µL volume by gavage. Feces 
were collected 24 hours after infection. Mice were euthanized 96 hours post-
infection and organs harvested, homogenized, serially diluted, and plated on LB 
agar with appropriate antibiotics for enumeration of CFU. For the murine typhoid 
model, mice were treated with 75 µL sterile water by gavage. Mice were then 
infected and euthanized as above. 
 EPEC mouse infections were performed essentially as previously 
described [209]. Mice were infected with approximately 108 CFU in 100 µL 
volume by gavage. Feces were collected every other day for 9 days. Mice were 
euthanized 10 days post-infection. The aboral 5 cm of small intestine, the entire 
cecum, and the entire colon were collected. Intestinal contents were exposed 
through a longitudinal incision. The intestinal segment was placed into sterile 
PBS and vigorously agitated to remove intestinal contents. Intestinal tissue was 
washed in sterile PBS to remove remaining ingesta. Intestinal contents and 
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tissue were homogenized separately, serially diluted, and plated on MacConkey 
agar and LB agar with appropriate antibiotics to enumerate CFU.  
 
Histopathology  
 Samples from mouse ileum, cecum, and transverse colon were collected 
96 hours post-infection and fixed in formalin. All tissues were routinely 
processed and stained with hematoxylin and eosin. All histologic analyses were 
performed by a blinded veterinary pathologist. Tissues were scored (0-4) for 
each of the following parameters: polymorphonuclear cell (PMN) infiltration, 
mononuclear leukocyte infiltration, crypt abscess, submucosal edema, villus 
blunting, and epithelial damage as described [10, 28, 90, 210]. 
 
msDNA isolation 
 msDNA was isolated from aerobic late log phase cultures normalized by 
OD600. Bacteria were lysed as for plasmid isolation (Qiagen Mini-prep) and 
msDNA isolated from the filtered fraction and subsequent ethanol precipitation. 
msDNA was visualized using a native polyacrylamide gel with in-gel ethidium 
bromide staining.  
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Invasion assays 
 Cell lines were purchased from American Type Culture Collection (ATCC) 
and used within 15 passages. HeLa cells (human cervical adenocarcinoma 
epithelial, ATCC CCL-2) were grown as recommended by ATCC. HeLa cells 
were seeded in 24-well plates at 5 x 104 cells/well approximately 24 h prior to 
infection.  
 Late-log phase cultures were prepared by inoculating 10 ml LB broth with 
0.3 ml overnight shaking culture. Flasks were grown at 37°C with agitation for 3 
hours. Bacteria were collected by centrifugation at 8000 x g for 90 seconds, 
resuspended in an equal volume of Hanks’ buffered saline solution (HBSS, 
Mediatech) and added directly to mammalian cells seeded in 24-well plates for 
10 minutes. The multiplicity of infection was approximately 50. Non-internalized 
bacteria were removed by aspiration. Monolayers were washed three times in 
HBSS and were then incubated in growth media until 30 min post-infection. 
Thereafter, gentamicin was added at 50 µg/ml from 30-90 min post-infection to 
kill extracellular bacteria and reduced to 10 µg/ml from 90 min post-infection. For 
enumeration of intracellular bacteria, monolayers were washed once in 
phosphate-buffered saline, and then solubilized in 0.2% sodium deoxycholate 
and serial dilutions were plated on LB agar. 
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Data analysis 
 Statistical analysis was performed using GraphPad Prism 6. All data were 
log transformed prior to analysis. Statistical significance was set at P < 0.05 and 
was determined using a t-test or ANOVA where indicated.  
 
Proteomic analysis 
 Wild type and the ∆STM3846 and ∆msd mutants were incubated either 
aerobically or in an anaerobic chamber (Coy) for 4 hours on three independent 
occasions. Bacteria were pelleted and supernatants discarded. Cell pellets were 
resuspended in 100 mM NH4HCO3, pH 8.0 and lysed by vigorous vortexing in 
the presence of 0.1 mm silica/zirconia beads. Proteins were denatured and 
reduced with 8M urea and 5 mM dithiothrietol, respectively, for 30 minutes at 
60°C. The proteins underwent enzymatic digestion for 3 hours at 37 °C with 1/50 
enzyme/protein (w/w) ratio of sequencing-grade trypsin. The resultant peptides 
were desalted for mass spectrometric (MS) analysis using C18 solid phase 
extraction cartridges (50 mg, 1 mL, Discovery, Sulpelco). The cartridges were 
activated with methanol, followed by equilibration with 0.1% TFA before loading 
the samples. The cartridges were then washed with 5% acetonitrile (ACN)/0.1% 
TFA and eluted with 80% ACN/0.1% TFA. Eluted peptides were concentrated in 
the vacuum centrifuge and diluted to a concentration of 0.5 mg/mL with water for 
the MS analysis.   
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 Digested peptides were loaded into capillary columns (75 µm x 35 cm, 
Polymicro) packed with C18 beads (3 µm particles, Phenomenex) connected to 
a custom-made 4-column LC system [211]. The elution was performed using the 
following gradient: equilibration in 5% B solvent, 5-8% B over 2 min, 8-12% B 
over 18 min, 12-35% B over 50 min, 35-60% min over 27 min and 60-95% B 
over 3 min. (solvent A: 0.1% FA; solvent B: 90% ACN/0.1% FA) and flow rate of 
300 nL/min. Eluting peptides were directly analyzed either on an Orbitrap (LTQ 
Orbitrap Velos, Thermo Scientific, San Jose, CA) mass spectrometer using 
chemically etched nanospray emitters [212]. Full scan mass spectra were 
collected at 400-2000 m/z range and the ten most intense ions were submitted 
to low-resolution CID fragmentation once (35% normalized collision energy), 
before being dynamically excluded for 60 seconds.  
 Tandem mass spectra were searched with MSFG+ against Salmonella 
enterica serovar Typhimurium 14028s and common contaminant sequences 
(downloaded from NCBI, all in forward and reversed orientations), using the 
following parameters: (i) partial tryptic digestion, (ii) 50 ppm parent mass 
tolerance, (iii) methionine oxidation as a variable modification. The peptides 
were filtered with a MSGF probability score [213] ≤ 1x10-9. Peak areas for each 
peptide were retrieved using the MultiAlign tool [214], and to ensure the quality 
of peptide-to-peak matching, the data was filtered with a Statistical Tools for 
AMT tag Confidence (STAC) score ≥ 0.7 and uniqueness probability ≥ 0.5 [215]. 
Additionally, proteins were required to have at least 2 peptides and at least one 
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peptide with STAC ≥ 0.9. Peptide abundance values were rolled-up into proteins 
using Qrollup tool, available in DAnTE [216]. Abundance values for each protein 
in all conditions (WT, mutants, anaerobic, aerobic conditions, biological 
replicates, and technical replicates), 32 in all, were used to calculate a Z-score 
for each measurement. The Z-score transformation enables comparisons of 
trends across conditions and proteins to identify relevant abundance changes.  
 
Results 
 Retron reverse transcriptases, including the STM3846 reverse 
transcriptase of the St-85 retron, use msr to prime reverse transcription of the 
msd template sequence to produce msDNA [117]. In order to establish that this 
msDNA, and not some other potential product of the STM3846 RT, mediates 
STm colonization of the intestine, we generated a non-polar deletion of msd 
(Figure 3.1A). Neither the ∆STM3846 mutant nor the ∆msd mutant produce 
msDNA and its production can be restored in both mutants by complementation 
in trans (Figure 3.1B). The additional ORF, STM3845, is dispensable for msDNA 
production.  
 We used the murine colitis model [28], which responds to NTS infection 
with profound neutrophilic inflammation in the cecum, to dissect the function of 
the retron in intestinal colonization. We confirmed the requirement for STM3846 
colonization of the inflamed intestine in this model (Figure 3.1C). In addition,  
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Figure 3.1: msDNA is produced by msd and STM3846 and is essential for 
Salmonella to colonize the intestine and grow in anaerobic conditions. (A) Genomic 
context of the retron St-85 (adapted from [106]). (B) Native polyacrylamide gel with in-gel 
ethidium bromide staining depicting msDNA (arrowhead). (C) Competitive index (CI 
WT/mutant) of WT vs ∆STM3846 bearing empty vector (closed circles; n=4) or WT vs 
complemented ∆STM3846 mutant (open circles; n=4) in the murine colitis model. (D) CI of 
WT vs ∆msd bearing empty vector (closed circles; n=5) or WT vs complemented ∆msd 
mutant (open circles; n=5) in the murine colitis model. Statistical significance was 
determined by a t-test with * P < 0.05 WT vs mutant and ** P < 0.05 between infection 
groups. (E and F) Anaerobic growth of WT (closed circles), ∆STM3846 (E) or ∆msd (F) 
with empty vector (open square), and complemented ∆STM3846 (E) or complemented 
∆msd (F) mutant (open diamond) in LB broth. Each data point is the mean +/- SEM of 
three independent experiments. MLN – mesenteric lymph node; PP – Peyer’s patches. 
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both the ∆msd and ∆STM3846 mutants have indistinguishable phenotypes, 
suggesting that the effect of deletion of the RT is mediated by the msDNA itself. 
The ability of each of these mutants to colonize the intestine is rescued by 
complementation in trans (Figures 3.1C and 3.1D). In cell culture, the ∆msd 
mutant invades epithelial cells at a level only mildly reduced compared to the 
isogenic wild type (Figure 3.2A and 3.2B) suggesting that reduced tissue 
invasion is not the likely cause of the phenotype we observed during infection of 
animal models. Our findings definitively link msDNA to the ability of Salmonella 
to colonize the intestine.  
 The intestine is a specialized and highly diverse niche. Oxygen tensions 
within the lumen decline from the stomach to the colon [58, 59] and there is a 
gradient of increasing oxygen tension from the center of the lumen towards the 
epithelium [60]. Enteric pathogens must replicate in this hypoxic setting using 
both aerobic and anaerobic metabolic pathways [217, 218] and express genes 
necessary for virulence in order to compete with resident microflora and colonize 
the host efficiently. To determine whether the intestinal colonization defect of the 
STm msDNA mutants is due to an inability to grow in oxygen limited conditions, 
we measured the growth of our mutants in the absence of oxygen. Both mutants  
unable to produce msDNA have severe growth defects in anaerobic conditions 
(Figure 3.1E and 3.1F), while the growth of these mutants in the presence of 
oxygen is similar to the isogenic WT (Figure 3.3A-D). The necessity for msDNA  
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during anaerobic growth is consistent with the inability of msDNA-deficient 
mutants to efficiently colonize the intestine. 
 
  
 
 We hypothesized that msDNA might act as a trans regulator of gene 
expression for two reasons. First, small RNAs are well known to have regulatory 
properties through base pairing with DNA or mRNA transcripts [219]. Second, 
substantial over-expression of msDNA from one strain of E. coli in a 
heterologous strain lacking a retron resulted in small changes in the proteome 
[140]. To determine whether the msDNA produced by the St-85 retron might 
have regulatory properties, we evaluated the proteome of WT and msDNA-
deficient mutants (∆STM3846 and ∆msd) at late exponential phase, a time at 
Figure 3.2: The ∆msd mutant has only a mild invasion defect in tissue cultured 
epithelial cells. (A) Invasion efficiency of ∆STM3846 and ∆msd mutants into HeLa cell 
monolayers normalized to the efficiency of the WT at 1 h post-infection. (B) Fold-
replication of ∆STM3846 and ∆msd mutants 7 h post-infection/1 h post-infection 
normalized to WT fold-replication. Bars represent the mean +/- SD. Invasion was 
measured on five and intracellular replication on three separate occasions. * P<0.05. 
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which the retron is expressed and msDNA is produced (Figure 3.1B and [220]), 
in both the presence and absence of oxygen. Of the 1505 proteins identified, 
there were no significant differences in protein abundance between the WT and 
mutants in the presence of oxygen (Figure 3.4A). This finding is not surprising 
given that mutants lacking msDNA have no known phenotypes when grown in 
standard laboratory conditions (Figure 3.3A-D). In addition, very few proteins 
differed in abundance between the two mutants, consistent with the hypothesis 
that the reverse transcriptase and msDNA operate in the same biological 
pathway.  
 
 
Figure 3.3: The aerobic growth kinetics of msDNA mutants is equivalent to WT in 
rich and minimal media. Aerobic growth of WT and ∆STM3846 mutant in (A) LB and (B) 
M9 minimal media and ∆msd mutant in (C) LB and (D) M9 minimal media. Each data 
point is the mean +/- SEM of three independent experiments. 
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Figure 3.4: Proteins needed for anaerobic metabolism are dysregulated in mutants 
lacking msDNA. (A) Z-scores of 148 of 1505 total proteins identified from WT (n=3) and 
∆msd (n=2) and ∆STM3846 (n=3) mutant cultures grown in both aerobic and anaerobic 
conditions. Functions of selected proteins are listed to the right of the heat map. (B-G) 
Number of generations of anaerobically grown WT and ∆STM3846 mutant in LB with added 
electron acceptor [B – nitrate (40 mM), C – fumarate (40 mM), D – DMSO (1% v/v), E – 
thiosulfate (40 mM) or control (F – NaCl (40 mM) or G – LB only)]. Each assay was 
performed on four separate occasions; each data point is mean +/- SEM. Statistical 
significance determined by t-test with * P<0.05. 
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In anaerobic conditions however, we identified 238 proteins that differed 
in abundance between the wild type and msDNA-deficient mutants. Forty-three 
percent of proteins with reduced abundance in the mutant were involved in 
amino acid and carbohydrate transport/metabolism and energy 
production/conversion (Figure 3.5A). Twenty-five percent of all proteins of 
altered abundance did not belong to a functional grouping (Figure 3.5A and 
3.5B). The abundance of numerous proteins known to be important for 
anaerobic growth was severely reduced, including proteins for 1,2 propanediol 
utilization [91], ethanolamine utilization [90], anaerobic sn-glycerol-3-phosphate 
utilization [221], anaerobic vitamin B12 biosynthesis [222], and serine/threonine 
degradation [223]. 
 
 
 
Figure 3.5: Functional groupings of dysregulated proteins in msDNA mutants. (A) 
Proteins reduced in abundance and (B) proteins increased in abundance in msDNA 
mutants as determined by clusters of orthologous grouping [183]. 
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 Utilization of tetrathionate, nitrate, and fumarate as terminal electron 
acceptors is essential for the biology of facultative anaerobes (Salmonella and 
E. coli) in the intestine of mammals [88, 217, 218, 224, 225]. NTS benefit from 
the host inflammatory response by using the alternate electron acceptors 
tetrathionate, generated by the neutrophilic respiratory burst, and nitrate, 
generated by the epithelium in response to infection [88, 89, 225]. Numerous 
proteins involved in reduction of anaerobic electron acceptors [62] were altered 
in abundance between msDNA mutants and wild type bacteria during anaerobic 
growth (Figure 3.6). Proteins important for the reduction of thiosulfate (PhsAB) 
 
 
 
Figure 3.6: Anaerobic carbon metabolism is severely disrupted in msDNA-deficient 
mutants. Proteins necessary for a given reaction are listed beside the reaction. Proteins 
listed in blue are decreased in abundance, in red are increased in abundance, and in green 
are unchanged in abundance in the mutants. Proteins shown in black were not observed. 
Boxed proteins are those alternate anaerobic electron acceptors Figure adapted from [241]. 
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and sulfide (AsrC) were of low abundance (Figure 3.4A). In addition, proteins 
necessary for reduction of DMSO (DmsA, STM4305.s) and fumarate (FrdA) 
were also of low abundance in msDNA mutants, although they did not meet our 
stringent criteria for statistical significance. Expression of genes necessary to 
utilize alternate electron acceptors is often induced by the presence of the 
electron acceptor [62] so the absence of a statistically significant reduction in 
some of these proteins is not surprising since these compounds were not 
present in the growth conditions. Interestingly, NapA, encoding the periplasmic 
nitrate reductase [62], was one of the proteins that was increased in abundance 
in msDNA deficient mutants compared to the WT and there was no change in 
the abundance of NarGH, one of the two other nitrate reductase complexes. 
These data are consistent with the growth defect of our mutants in anaerobic 
conditions, and suggest that in msDNA-deficient mutants there is severe 
dysregulation of proteins necessary for reduction of terminal electron acceptors 
needed during anaerobiosis. 
 We determined the effects of the addition of various terminal electron 
acceptors on growth of the STM3846 mutant in anaerobic conditions. We found 
that the addition of fumarate, DMSO, or thiosulfate to the culture media during 
anaerobic growth did not restore the growth defects of strains lacking msDNA 
(Figures 3.4C-E and 3.7B-C). Thus, the reduced abundance of thiosulfate 
reductase, sulfide reductase, two DMSO reductases, and fumarate reductase 
noted in our proteomic analysis translates to an inability to use these  
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Figure 3.7: Nitrate, but not fumarate or DMSO, rescues the anaerobic growth defect 
of the ∆STM3846 mutant to WT levels in LB. (A) Anaerobic growth of WT, ∆STM3846 
mutant, a mutant lacking all three nitrate reductases (∆narG ∆narZ ∆napA), and ∆narG 
∆narZ ∆napA ∆STM3846 in the presence (black bars) or absence (white bars) of nitrate 
after a 4-hour incubation. (B) Anaerobic growth of WT, ∆STM3846 mutant, a mutant 
lacking the fumarate reductase (∆frdA), and ∆frdA ∆STM3846 in the presence (black bars) 
or absence (white bars) of fumarate after a 4-hour incubation. (C). Anaerobic growth of 
WT, ∆STM3846 mutant, a mutant lacking all three putative DMSO reductases (∆STM0964 
∆STM2530 ∆STM4305), and ∆STM0964 ∆STM2530 ∆STM4305 ∆STM3846 mutants in 
the absence (black bars) or presence (white bars) of DMSO after a 4 hour incubation. 
Bars represent mean +/- SEM. * indicates significant difference between mutant and WT 
for that condition (P<0.05 by ANOVA). ** indicates significant difference between 
conditions (P<0.05 by t-test). 
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compounds as terminal electron acceptors to support anaerobic growth. We 
further determined that the addition of nitrate to culture medium rescued the 
anaerobic growth of the reverse transcriptase mutant (Figure 3.4B and 3.7A). 
These data are consistent with our proteomic data that show that mutants 
lacking msDNA have adequate NarGH, and an increased amount of NapA, 
allowing these strains to use nitrate as a terminal electron acceptor during 
anaerobic growth.   
 In the presence of an intact TTSS-1, NTS induce an inflammatory 
response that includes recruitment of luminal neutrophils and induction of 
inducible nitric oxide synthase by the epithelium [51, 88, 225] resulting in 
generation of tetrathionate and nitrate as available terminal electron acceptors in 
the inflamed intestine. To determine whether the colonization defects we 
observed were dependent on a functional TTSS-1 and host neutrophilic 
inflammatory response, we performed competitive infection experiments 
between the virulent WT and ∆STM3846 mutant both in the presence and 
absence of SPI-1 (Figure 3.8A). We observed that a ∆STM3846 mutant 
colonizes poorly in the intestine and associated organs. The modest colonization 
defect may be due to an inability to utilize carbon and amino acid sources within 
the inflamed intestine [90], or due to poor growth as compared with WT prior to 
the host inflammatory response. Interestingly, the colonization defect of the 
∆STM3846 mutant in the mouse cecum was exacerbated in the absence of a 
functional TTSS-1, suggesting that a robust inflammatory response partially  
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rescues mutants unable to produce msDNA (Figure 3.8A). Consistent with this 
finding, both the small and large intestines, which lack appreciable neutrophilic 
inflammation (Figure 3.8C), are poorly colonized with the ∆STM3846 mutant in 
mice inoculated with this strain alone (Figures 3.8B and 3.8C). In murine models 
that do not develop a neutrophilic infiltrate in the intestine in response to 
infection (murine typhoid model), the ∆STM3846 mutant also colonizes poorly 
after oral infection (Figures 3.9A and 3.9B). Our results suggest that STM3846 is 
essential for STm to colonize the intestine, a defect that is partially rescued in 
the presence of a profound host inflammatory response. 
Figure 3.8: The STM3846 reverse transcriptase mediates intestinal colonization of 
Salmonella Typhimurium. (A) Competitive index (CI WT/mutant) of WT vs ∆STM3846 
(n=5 mice; closed circles) and ∆SPI-1 vs ∆SPI-1 ∆STM3846 (n=5; open squares) 4 days 
post infection in the murine colitis model. (B) Organ colonization of mice infected with 
either WT (n=4; closed circles) or ∆STM3846 mutant (n=5; open squares) in the murine 
colitis model. (C) Mean of histologic scores from indicated intestinal segments from mice 
in (B). Each point represents data from a single mouse with median and interquartile 
range indicated. Statistical significance determined as in figure 3.1. PP – Peyer’s patches; 
SI – small intestine; LI – large intestine.  
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 The msDNA of STm is similar in predicted secondary structure to msDNA 
of other enteric pathogens including enteropathogenic E. coli [112], a close 
phylogenetic relative of STm. Despite the fact that the pathology caused by 
these organisms is quite different, both colonize the intestine and cause 
diarrheal illness in susceptible hosts. We hypothesized that the RT of EPEC 
O127:H6, a serotype previously shown to produce msDNA [120], is also 
necessary for intestinal colonization. An EPEC mutant lacking the RT colonizes 
the intestine of mice poorly, both in the luminal contents and tissue adherent 
bacteria (Figure 3.10A and B). These data suggest that the importance of retron 
Figure 3.9: The ∆STM3846 mutant colonizes the non-inflamed intestine poorly in the 
murine typhoid model. (A) Organ colonization of mice infected with either WT (closed 
circles; n=5) or ∆STM3846 mutant (open squares; n=5). (B) Mean histologic score from 
mouse organs in (A). Each point represents a single mouse with median and interquartile 
range indicated. Statistical significance between WT and ∆STM3846 mutant as determined 
by a t-test is indicated by * (P<0.05). 
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reverse transcriptases during intestinal infection is not restricted to salmonellae, 
and thus are likely to be more broadly applicable to enteric pathogens.  
 
 
  
 
 
 Discussion 
 We have used S. Typhimurium, a model enteric pathogen to show that 
msDNA produced by a retron reverse transcriptase directs colonization of the 
intestine through regulation of proteins necessary for central anaerobic 
metabolism. Recent evidence suggests that Salmonella induces a host 
inflammatory response to exploit alternate energy sources and electron 
Figure 3.10: Enteropathogenic E. coli is dependent on the retron reverse 
transcriptase to persist within the murine intestine. Fecal shedding (A) of WT 
(closed circles) and ∆RT mutant (open squares) throughout infection and (B) in 
intestinal contents (luminal bacteria) and washed tissue (tissue adherent bacteria) after 
10 days competitive infection. Statistical significance was determined as for figure 3.1.  
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acceptors within the inflamed intestine [88, 90, 225]. We have shown that some 
of these processes in STm are altered in mutants unable to produce msDNA, 
along with many other processes with less clearly defined roles in pathogenesis. 
While the regulatory targets of msDNA may differ between species, the role of 
retron reverse transcriptases in intestinal colonization by enteric pathogens is 
likely ubiquitous, as we have shown similar phenotypes for two pathogens 
lacking a retron reverse transcriptase.  
 Decades of precedent indicate that inhibition of reverse transcriptases, 
where they are critical for biology of an organism (retroviruses), is a mainstay of 
effective therapy against these infections. Further studies elucidating the 
mechanism of msDNA function and its regulatory targets may lead to generation 
of novel therapeutics to target increasingly antibiotic-resistant bacteria. 
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 CHAPTER IV 
A SALMONELLA REGULATOR MODULATES GROWTH WITHIN THE 
MICROBIAL COMMUNITY OF THE INTESTINE 
 
Overview 
 Salmonella Typhimurium has numerous mechanisms for colonization of 
the mammalian intestine. It is essential for Salmonella to compete with the host 
and resident microflora for nutrients in this niche. Phosphonates, molecules 
characterized by stable carbon-phosphorus bonds, are microbial-derived 
products that are produced by microorganisms to store phosphorus, and some 
have antimicrobial properties. Salmonella lacks the capability to produce these 
molecules but can use them, but role of phosphonate metabolism during enteric 
infection has not been explored. We previously showed that a transcriptional 
regulator encoded by STM3602 is needed for colonization of the intestine of 
calves. Here we report that the necessity of for colonization of the murine 
intestine depends on the composition of the intestinal microflora. STM3602 is 
needed for full activation of the type-3 secretion system-1 and adequate 
epithelial cell invasion. The ∆STM3602 mutant grows poorly when 
phosphonoacetic acid (PA) is the sole phosphorus source, but this mutant is 
capable of utilizing 2-aminoethylphosphonate. Finally, we show that the enzyme 
required for PA breakdown, phnA, is not under the control of STM3602 
suggesting an additional mechanism for utilization of PA in S. Typhimurium. 
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Together, these data suggest that STM3602 has multiple regulatory targets that 
are necessary for survival within the complex microbial community in the 
intestine. Elucidation of the regulon of this gene is a fascinating area of future 
work and will likely illuminate important new pathways needed for colonization of 
the host. 
 
Introduction 
 Non-typhoidal salmonellae (NTS) compete in a complex microbial 
community during infection of the host. Nutrient availability within the intestinal 
lumen varies along the length of the intestine and both the host and 
microorganisms vie for nutrients in this environment. To gain a foothold during 
infection, Salmonella Typhimurium (STm) exhibits numerous mechanisms to 
gain nutrients and survive in this niche. One notable strategy is the generation of 
a host inflammatory response with the products of the type 3-secretion system-1 
(TTSS-1) to alter the composition of the luminal contents. Through the host 
inflammatory response, tetrathionate and nitrate are produced which STm uses 
as terminal electron acceptors [88, 225]. Host-derived sugars such as 
ethanolamine are also released and utilized as energy sources during 
inflammation [90].  
 Metals, such as iron, zinc, and manganese are highly sought after during 
infection (reviewed in [93]. Siderophores are produced by Enterobacteriaceae to 
scavenge iron. Salmonellae modify enterobactin to salmochelin [226] to 
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scavenge iron from host-derived lipocalin-2 in the inflamed intestine [227]. Zinc 
is sequestered by host-derived calprotectin during intestinal inflammation, a 
process which Salmonella overcomes with a specialized high-affinity zinc 
transporter to acquire this nutrient during infection [94]. While these are some 
essential mechanisms by which salmonellae acquire nutrients to replicate in the 
intestine, it is highly likely that these represent only a small fraction of the 
potential mechanisms. 
 Phosphonates are molecules with stable carbon-phosphorus bonds. 
Microorganisms produce these molecules to store phosphorus during periods of 
phosphate limitation [151]. In addition to a metabolic utility of these molecules, 
some of these compounds have potent antimicrobial activity [153, 154] and may 
be produced by microbes for interspecies competition. The carbon-phosphorus 
bond is produced by the action of the coupled enzymes phosphoenolpyruvate 
phosphomutase (Ppm) and phosphonopyruvate decarboxylase (Ppd) to 
generate phosphonoacetaldehyde, which is converted to 2-
aminoethylphosphonate (2-AEP) by AEP transaminase [151, 154]. These are 
the first steps in the production of compounds containing the stable carbon-
phosphorus bond. Although Salmonella lacks genes for the biosynthesis of 
phosphonates, it has the capability to utilize these compounds [160, 161].  
 We previously found that a mutant in ∆STM3602 colonized ligated ileal 
loops in calves poorly [106]. In this model, Salmonella Typhimurium is inoculated 
into intestinal segments with undisturbed microflora and the host responds with 
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a profound neutrophilic inflammatory response [45, 46]. Thus, salmonellae must 
both compete with the naturally present microbiota and withstand the host 
inflammatory response to colonize in this model.  
 We report that STM3602 is necessary for colonization of the intestine of 
mice regardless of the composition of the microflora. We have found that 
STM3602 is needed for full activation of the TTSS-1 and adequate epithelial cell 
invasion. However, this gene is dispensible for TTSS-2 expression and 
intracellular replication. The ∆STM3602 mutant is defective for growth with 
phosphonoacetic acid (PA) as a sole phosphorus source, but is capable of 
utilizing 2-AEP. Finally, we show that the known enzyme for PA breakdown, 
phnA, is not under the control of STM3602 suggesting an additional mechanism 
for utilization of PA. Our data suggest that STM3602 has a diverse regulon 
including numerous genes needed for survival within the intestine.  
 
Methods 
Bacterial strains and plasmids 
 All bacterial strains are derivatives of ATCC 14028s. Unless stated 
otherwise, bacteria were grown in Luria-Bertani (LB) broth or LB agar 
supplemented with the following antibiotics as appropriate: kanamycin (50 
mg/L), nalidixic acid (50 mg/L), carbenicillin (100 mg/L), streptomycin (100 mg/L) 
or chloramphenicol (20 mg/L). Mutants were constructed by a modification of the 
λ−red recombination technique and antibiotic cassettes removed as described 
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[97, 207]. Chromosomal transcriptional fusions to lacZY were constructed as 
described [228]. All mutations were moved into a clean genetic background by 
bacteriophage P22-mediated transduction [169]. 
 
Mouse infection 
 The Texas A&M University Institutional Animal Care and Use Committee 
approved all animal experiments. All mouse experiments were performed using 
10-12 week old female C57BL/6J or CBA/J mice as indicated (Jackson 
Laboratories) as previously described [28].  
 For the acute murine colitis model, mice were administered 20 mg 
streptomycin in 75 µL sterile water by gavage. Twenty-four hours after 
treatment, mice were infected with approximately 108 CFU of an equivalent 
mixture of WT and mutant bacteria in 100 µL volume by gavage. Feces were 
collected 24 hours after infection. Mice were euthanized 96 hours post-infection 
and organs harvested, homogenized, serially diluted, and plated on LB agar with 
appropriate antibiotics for enumeration of CFU.  
 For the chronic murine colitis model, mice were administered 20 mg 
streptomycin in 75 µL water or 75 µL sterile water by gavage. Forty-eight hours 
after treatment, mice were infected as above. Feces were collected on the 
indicated days and mice euthanized 14 days post-infection. Competitive index 
  85 
was determined by comparing the ratio of WT to mutant bacteria in the tissue to 
that of the inoculum. 
 
Calf ligated ileal loop infection 
 Six 3-6 week old Angus-cross calves were used for ligated ileal loop 
experiments as previously described [106]. 
 
Invasion assays 
 Cell lines were purchased from American Type Culture Collection (ATCC) 
and used within 15 passages. HeLa cells (human cervical adenocarcinoma 
epithelial, ATCC CCL-2) were grown as recommended by ATCC. HeLa cells 
were seeded in 24-well plates at 5 x 104 cells/well approximately 24 hours prior 
to infection.  
 Late-log phase cultures were prepared by inoculating 10 ml LB broth with 
0.3 ml overnight shaking culture. Flasks were grown at 37°C with agitation for 3 
hours. Bacteria were collected by centrifugation at 8000 x g for 90 seconds, 
resuspended in an equal volume of Hanks’ buffered saline solution (HBSS, 
Mediatech) and added directly to mammalian cells seeded in 24-well plates for 
10 minutes. The multiplicity of infection was approximately 50:1 
(bacteria:eukaryotic cell) for HeLa cells. Non-internalized bacteria were removed 
by aspiration, monolayers washed three times in HBSS and then incubated in 
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growth media until 30 minutes post-infection. Thereafter, gentamicin was added 
at 50 µg/ml from 30-90 minutes post-infection to kill extracellular bacteria and 
the media was replaced with media containing 10 µg/ml gentamicin from 90 
minutes post infection. For enumeration of intracellular bacteria, monolayers 
were washed once in phosphate-buffered saline, solubilized in 0.2% sodium 
deoxycholate and serial dilutions were plated on LB agar. 
 
β-galactosidase assays 
 For induction of SPI-1 expression, bacterial cells bearing plasmid 
constructs were grown overnight in LB with appropriate antibiotics. Overnight 
cultures were diluted 1:100 and incubated at 37˚C with agitation for 3 hours. 
SPI-2 inducing media was used as described (5mM KCl, 7.5mM (NH4)2SO4, 
0.5mM K2SO4, 8µM MgCl2, 337µM KH2PO4, 80mM MES, 0.3% (v/v) glycerol, 
0.1% (v/v) casamino acids, pH 5.8) [229]. Cells were grown overnight in SPI-2 
inducing media then diluted 1:50 and incubated for an additional 24 hours for 
evaluation of SPI-2 expression. For evaluation of the expression of phnA in the 
presence of PA, overnight cultures were diluted 1:100 into LB with 40mM MOPS 
at pH 6.8 with the indicated phosphorus source. Cultures were incubated at 
37˚C with agitation for 3 hours. 
 β-galactosidase activity was determined using standard methodology 
[230]. Briefly, bacterial cells were pelleted by centrifugation and resuspended in 
Z-buffer (60mM Na2HPO4, 40mM NaH2PO4, 10mM KCl, 1mM MgSO4, 50mM b-
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mercaptoethanol). The OD600 was taken of bacterial cells in Z-buffer. The cells 
were permeabilized with chloroform and 0.1% SDS prior to addition of substrate 
(o-nitrophenyl-β-D-galactoside; ONPG 4 mg/mL). The reactions were performed 
at 28˚C and were stopped with 1M Na2CO3 for determination of OD420 and 
OD550. β-galactosidase activity (Miller units) was calculated using the following 
equation: 1000 x [OD420 – (1.75 x OD550)] / [time x volume x OD600]. 
 
Phosphonate growth 
 Modifications were made to a phosphorus-limited minimal medium [231] 
to assess the ability of different bacterial strains to utilize different phosphorus 
sources. The final media composition (MMMM) was as follows: 20 mM NH4Cl, 
2.5 mM Na2SO4, 80 mM NaCl, 0.35 mM CaCl2, 20 mM KCl, 40 mM MOPS, 1 
mM MgSO4, 0.01 mM FeSO4, 0.2% glucose, pH 6.8. Phosphorus sources were 
Na2HPO4 (Pi, Sigma), 2-aminoethylphosphonate (2-AEP, Sigma), and 
phosphonoacetic acid (PA, Sigma) added at the concentrations indicated. 
Bacterial strains were grown overnight at 37˚C with agitation in MMMM with 
Na2HPO4 at the indicated concentration. Overnight cultures were diluted 1:100 
into MMMM with indicated phosphorus source. Aliquots were removed, serially 
diluted, and plated to determine CFU. 
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Data analysis 
 All data were log transformed prior to analysis. Statistical significance was 
determined using Student’s t-test with significance set at P < 0.05. 
 
Results 
STM3602 in intestinal colonization  
 We have previously shown that STM3602 is necessary for STm to 
colonize the intestine of calves [106]. We used the murine colitis model [28] to 
further dissect the function of this gene during infection. In the murine colitis 
model, mice are treated with high doses of streptomycin prior to infection with 
STm to alter the composition of microflora within the intestine, allowing 
colonization and development of a neutrophilic inflammatory response. We 
found that the ∆STM3602 mutant has a fitness defect in feces by 24-hours post-
infection and in Peyer’s patches and mesenteric lymph nodes by 96-hours post 
infection (Figure 4.1). This defect is reversed by complementation in trans. 
Failure to observe a statistically significant defect of the ∆STM3602 mutant in 
the murine cecum was likely due to large variation in competitive index between 
animals. Overall, these results are consistent with a requirement of STM3602 for 
colonization of the intestine of mammals in the presence of a profound 
inflammatory response. 
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STM3602 and SPI-1 regulation 
 Salmonellae possess two type-3 secretion systems, encoded by 
Salmonella pathogenicity islands 1 and 2 (SPI-1 and SPI-2). The current dogma 
is that the TTSS-1 and its associated effectors are essential for invasion of non-
phagocytic epithelial cells and penetration of the intestinal epithelium [51, 77]. 
The TTSS-2 is needed for maintenance of the Salmonella-containing vacuole 
Figure 4.1: The ∆STM3602 mutant poorly colonizes the murine Peyer’s patches and 
mesenteric lymph nodes during acute colitis. Ten C57BL/6 mice were treated with 
streptomycin (20mg) then infected with ~108 CFU of an equivalent mixture of WT and 
∆STM3602 mutant bearing an empty plasmid (pWSK29) or complementing plasmid 
(pSTM3602) 24-hours after antibiotic treatment. Feces (F) were collected 24 hours after 
infection and mice were euthanized 24-hours post-infection for collection of Peyer’s 
patches (PP), mesenteric lymph nodes (MLN), and cecum (C). Competitive index (CI) was 
determined by comparing the ratio of WT to mutant in the tissue to that of the inoculum. 
Each data point represents a single mouse with median and interquartile range indicated 
by horizontal bars. Significant difference in CI is indicated by an asterisk (*) and difference 
between groups is indicated by two asterisks (**) with P < 0.05. 
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and intracellular replication [187]. We hypothesized that the intestinal 
colonization defect of ∆STM3602 mutants could be due to a reduced ability of 
these mutants express the TTSS-1.  
 Using a plasmid containing lacZY under the control of a promoter of prgH, 
a TTSS-1 structural gene, we observed that the ∆STM3602 mutant activates the 
prgH promoter less efficiently in SPI-1 inducing conditions than when the fusion 
is in the WT background (Figure 4.2A). Deletion of STM3602 results in a similar 
reduction in invasion efficiency in cultured epithelial cells (Figure 4.2B). 
Conversely, the ∆STM3602 mutant is capable of full activation of TTSS-2 
apparatus (ssaG) and effector promoters (sseJ) (Figure 4.2C) as well as survival 
within cultured epithelial cells (Figure 4.2D).  
 While these results are suggestive of a role of STM3602 in the complex 
regulatory network of SPI-1, the invasion defect of strains lacking STM3602 is 
small, and is unlikely to fully explain the phenotype that the ∆STM3602 mutant 
displays during infection in murine and bovine models. The secretion of all 5 
effectors sipAsopABDE2 is essential for full epithelial cell invasion and pathology 
in the calf model of infection [51, 77] while removal of a single effector causes 
only mild attenuation. In addition, we observed a statistically significant 
colonization defect of the ∆STM3602 mutant in a ∆SPI-1 background in 
competition with a ∆SPI-1 mutant in calf ligated ileal loops (Figure 4.3). The 
median competitive index of the ∆STM3602 mutant in the SPI-1 deletion 
background was 2.14 (1.2-2.9; interquartile range [IQR]), similar to that of  
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Figure 4.2: The ∆STM3602 mutant has reduced invasion efficiency into cultured 
epithelial cells due to poor activation of SPI-1. (A) Activation a terminal SPI-1 
promoter (prgHp-lacZY) in SPI-1 inducing conditions as determined by β-galactosidase 
activity. (B) Invasion efficiency of ∆STM3602 and complemented ∆STM3602 mutants 
into HeLa cell monolayers normalized to the efficiency of the WT at 1 h post-infection. 
(C) Activation of two SPI-2 terminal promoters (sseJp-lacZY and ssaGp-lacZY) in SPI-2-
inducing conditions as determined by β-galactosidase activity. (D) Fold-replication of 
∆STM3602 and complemented ∆STM3602 mutants 7 h post-infection/1 h post-infection 
normalized to WT fold-replication. Bars represent the mean +/- SD. Assays were 
performed on three separate occasions. * P<0.05. 
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published data for the ∆STM3602 mutant in the WT background (median 1.7, 
1.3-3.0 IQR) [106]. These data suggest that STM3602 participates in additional 
pathways that result in the reduced fitness of the ∆STM3602 mutant during 
infection. 
 
 
 
 
 
Growth in phosphonoacetate as sole phosphorus source 
 Although Salmonella lacks genes for the biosynthesis of phosphonates, it 
has the capability to utilize these compounds (Figure 4.4 and reference [160, 
161]). STM3602 belongs to the GntR family of transcriptional regulators and 
Figure 4.3: The colonization defect of the ∆STM3602 mutant persists in the absence 
of an intact TTSS-1. Ligated ileal loops from 6 calves were inoculated with an equivalent 
mixture of ∆SPI-1 mutant and ∆STM3602 ∆SPI-1 double mutant. Loops were harvested 12 
hours after infection. Each data point represents a singe calf. Median and interquartile range 
of competitive index (WT/mutant) indicated with horizontal bars. Analyses for statistical 
significance determined as in figure 4.1. 
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shares a conserved domain with phnF, a regulator of the phosphonate utilization 
operon in E. coli [232]. However the putative mechanism of phosphonate 
degradation differs between E. coli and Salmonella. E. coli degrades 
phosphonates using the C-P lyase system encoded within a 14 gene operon 
(phnCDEFGHIJKLMNO) [233]. Salmonella has two loci annotated for  
 
 
 
 
 
degradation of phosphonates via the phosphonatase pathway, phnABO and 
phnVUTRWX [161]. There are four genes annotated for phosphonate 
degradation (Figure 4.4), phnW (STM0431; 2-AEP-pyruvate aminotransferase), 
Figure 4.4: Salmonella enzymes with an annotated role in phosphonate metabolism. 
See text for description. Not included is PhnO (STM4287), aminoalkylphosphonic acid N-
acetyltransferase. 
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phnX (STM0432; phosphonatase), phnA (STM4289; phosphonoacetate 
hydrolase), and phnO (STM4287; aminoalkylphosphonic acid N-
acetyltransferase) [160, 161]. The phnVUTRWX locus is under the control of the 
pho regulon and is activated under conditions of phosphate deprivation [161].  
 Based on the shared conserved domain with PhnF, we hypothesized that 
STM3602 regulates one or both of these phosphonate utilization loci. We chose 
to characterize the survival and growth of the ∆STM3602 mutant in media 
containing either 2-AEP or PA as the sole phosphorus source. When bacterial 
strains were grown in the presence of 5mM PA, the ∆STM3602 mutant 
replicated poorly (Figure 4.5C). However, this mutant has normal growth 
characteristics in the presence of either 5mM 2-AEP or Pi (Figure 4.5A-B) as 
sole phosphorus sources. PA is degraded to acetate and inorganic phosphate 
(Figure 4.4). One possible explanation for the phenotype of the ∆STM3602 
mutant in PA-containing medium is an inability to properly utilize or excrete 
acetate. However, the ∆STM3602 mutant exhibits similar growth kinetics to WT 
in the presence of both 5mM acetate and 5mM Pi (Figure 4.5D) suggesting a 
mechanism specific to metabolism of PA. These data suggest a role for 
STM3602 in phosphonoacetate utilization.    
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 Next, we determined the growth kinetics of the ∆STM3602 mutant in 
media with 5mM PA after phosphorus deprivation. When bacteria were grown in 
phosphorus-limiting conditions (0.5mM Pi) and transferred to media containing 
10 times more phosphorus in the form of PA, the ∆STM3602 mutant initially lost 
viability (Figure 4.6A-B) before recovering to the starting CFU. This defect was 
Figure 4.5: STM3602 is required for adequate growth with phosphonoacetic acid as a 
sole phosphorus source. (A-D) Growth curve of WT and ∆STM3602 in 5mM Pi (A), 2-AEP 
(B), PA (C) and 5mM sodium acetate with 5mM Pi (D). Bacteria were grown overnight in a 
minimal medium with 5mM Pi then diluted 1:100 into media with the indicated phosphorus 
or carbon additions. CFU were determined every 2 hours. 
 
 
0 2 4 6 8
105
106
107
108
109
1010
Time (hr)
C
FU
/m
L
Pi
WT
!STM3602
0 2 4 6 8
105
106
107
108
109
PA
Time (hr)
C
FU
/m
L
0 2 4 6 8
105
106
107
108
109
Acetate + Pi
Time (hr)
C
FU
/m
L
0 2 4 6 8
105
106
107
108
109
2-AEP
Time (hr)
C
FU
/m
L
A. C.
B. D.
  96 
reversed in the complemented strain (Figure 4.6A). A mutant deleted for phnA, a 
gene that encodes the phosphonoacetate hydrolase, had a significant growth 
defect in these conditions compared to the WT (Figure 4.6B). Interestingly, the 
growth of the ∆phnA mutant was significantly improved compared with the 
growth of the ∆STM3602 mutant. These results suggest that both STM3602 and 
phnA are needed for growth in the presence of PA. However, it is possible that 
they do not participate in the same pathway to metabolize this compound.  
 
 
 
 
Figure 4.6: The growth defect of the ∆STM3602 mutant with PA as a sole 
phosphorus source is reversed by complementation in trans and differs from a 
mutant in ∆phnA. Bacterial strains were grown overnight in 0.5 mM Pi and diluted 1:100 
into media with 5 mM PA. CFU were determined hourly. (A) Growth of WT, ∆STM3602 
bearing empty vector and complemented ∆STM3602 mutant. (B) Growth of WT, 
∆STM3602 and ∆phnA. CFU data were log transformed and statistical significance 
determined by ANOVA. (*) indicates significant difference in CFU between ∆STM3602 + 
pWSK29 and WT; ($) indicates significant difference between ∆phnA and WT; (#) 
indicates significant difference between ∆STM3602 and ∆phnA with P < 0.05. 
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Expression of phnA  
 The ∆STM3602 mutant grows poorly in the presence of PA. We 
hypothesized that STM3602 regulates the phnABO operon because phnA and 
STM3602 mutants both have growth defects when grown in PA as a sole 
phosphorus source. In order to test this hypothesis, we generated a mutant 
strain bearing allelic replacement of phnA (with the first 10 amino acids intact) 
with lacZY to monitor transcription from the phnA promoter. Using this construct, 
we found that the expression of phnA in rich media was not affected by the 
addition of PA at varying concentrations (Figure 4.7). In addition, we observed 
no effect of a deletion of STM3602 on the expression of phnA in these 
conditions during log phase growth (Figure 4.7), a time at which STM3602 is 
expressed [234]. These data suggest that the expression of phnA is not 
dependent on the presence of PA or STM3602 in rich medium. 
 
 
Figure 4.7: The expression of phnA is not affected by deletion of STM3602. The 
expression of phnA::lacZY was determined from log phase cultures in rich medium by 
measuring β-galactosidase activity in both the WT (black bars) and ∆STM3602 mutant 
(white bars) backgrounds. Bars represent the mean +/- SEM of 3 independent experiments.  
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Impact of microbiota on ∆STM3602 intestinal colonization  
 The first phosphonate to be discovered, 2-AEP, was identified in both the 
ruminal and duodenal contents of sheep [156]. This compound was associated 
with both ruminal protozoal and bacterial populations and was less abundant in 
defaunated animals compared with those with a normal microbial composition. 
Phosphonoacetic acid is one product of 2-AEP metabolism mediated by the 
enzyme PhnY. Although salmonellae lack a gene with this annotated function, it 
is likely that members of the microflora possess this gene to produce PA [151, 
159] as this gene has been found in Cyanobacteria, Proteobacteria and 
Firmicutes, phyla known to inhabit the murine intestine [235].  
 We hypothesized that the colonization defect of the ∆STM3602 mutant 
would correlate with the microbial composition of the host. We used the chronic 
carriage mouse model to determine the kinetics of the previously observed 
colonization defect. In competitive infection with the WT in the presence of 
streptomycin (altered microbiota), the ∆STM3602 mutant failed to colonize the 
intestine on day 1 whereas the colonization defect was only apparent in 
conventional mice beginning at day 5 (Figure 4.8). These results suggest that 
the colonization defect we observed occurs earlier in animals with disrupted 
microbiota than with intact microbiota.  
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Discussion 
 We report that the putative GntR family regulator STM3602 is necessary 
for colonization of the murine intestine, similar to published results of a 
colonization defect in the bovine intestine [106]. Two possible mechanisms for 
the observed colonization defect are a role for STM3602 in the activation of the 
TTSS-1 and in metabolism of the microbial-derived product, phosphonoacetic 
acid. Our data are consistent with a global regulatory role of STM3602 in 
modulating virulence and metabolism in the infected animal host. 
Figure 4.8: The ∆STM3602 mutant fails to colonize the intestine of mice with an 
altered microflora and fails to persist in the intestine of mice with an intact 
microflora. Ten CBA/J mice were treated with streptomycin (20mg; closed circles) or an 
equivalent volume of sterile water (open squares) and infected 48 hours later with ~108 CFU 
of an equivalent mixture of WT and ∆STM3602 mutant by gavage. Feces were collected on 
the indicated days. Significant difference in CI (WT/mutant) is indicated by an asterisk (*) 
and difference between groups is indicated by two asterisks (**) with P < 0.05. Analyses for 
statistical significance determined as in figure 4.1.  
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 2-AEP was the first phosphonate discovered from sheep rumen [155]. 
This compound is found in low amounts in feed and is associated with bacterial 
and protozoal populations within the intestine [156]. 2-AEP is also found in 
mammalian tissues [157, 236] likely from assimilation from microbial and feed 
sources because mammals lack the enzymes to produce such molecules [154]. 
Numerous marine bacterial phyla contain genes for the biosynthesis and 
degradation of phosphonates [151]. This finding is not restricted to the marine 
biosphere. The leading bacterial phyla containing phosphonate biosynthetic 
genes from mammalian and bird microbiome metagenomes are Firmicutes, 
Proteobacteria, and Bacteroidetes [152]. These phyla are abundant in the 
murine cecum, although the relative abundance of these phyla is substantially 
altered following streptomycin treatment [235].  
 STm lacks the enzymes for synthesis of phosphonates, but possesses 
four enzymes annotated for the metabolism of these molecules. We have shown 
that a mutant in ∆STM3602 has both a colonization defect in the intestine of 
mammals and fails to utilize phosphonoacetic acid as a sole phosphorus source. 
The relationship between these phenotypes remains unclear. We found that the 
∆STM3602 mutant fails to colonize the intestine of mice, regardless of whether 
mice have intact or altered intestinal microbiota. In addition to the difference in 
microbial composition, these two mouse models differ in the host response. Mice 
with altered microbiota infected with STm develop neutrophilic inflammation [38], 
whereas those with intact microbiota do not develop a neutrophilic inflammatory 
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response [25]. Thus, in addition to alterations in microflora composition, there is 
substantial difference in the host response that may affect the fitness of the 
mutant. It is also possible that the host acts as a source of phosphonates, 
having absorbed them from the microflora and incorporated them into 
phosphonolipids [157, 236]. Further studies evaluating the fitness of mutants 
unable to utilize phosphonoacetic acid and other phosphonates during intestinal 
inflammation in combination with evaluation of the PA content of intestinal fluid 
and tissue in conventional and germ-free mice will be very informative. 
 The locus needed for growth on 2-AEP (phnVUTSRWX) is under the 
regulatory control of the Pho regulon [161] but no studies have evaluated the 
regulation of the phnABO operon. Our data suggest that phnA is expressed at 
low levels in rich medium and that the expression of phnA is not induced in the 
presence of PA. Our data also suggest that the expression of phnA is not 
affected by deletion of STM3602. We measured phnA expression during log 
phase growth, a time when STM3602 is expressed [234]. The phosphorus 
content of LB broth is undefined, and it is possible that the expression profile of 
phnA would differ in the defined media in the presence of different phosphorus 
sources. The phenotypes of the ∆STM3602 mutant have subtle differences 
depending on starting culture conditions (Figures 4.5 and 4.6) so we can not rule 
out that different culture conditions would affect the expression of either 
STM3602 or the involvement of STM3602 in phnA expression.   
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 GntR family regulators have characteristic N-terminal DNA-binding 
domains and variable C-terminal small ligand binding domains [201, 237]. The 
crystal structure of phnF from E. coli has been solved and a small molecule 
ligand has been modeled into a binding site [237]. Despite this advance, we are 
not aware of any experimental data to confirm the identity of the small molecule 
ligand or the regulon of this gene. STM3602 shares a conserved domain with 
PhnF, but has only 23.4% amino acid identity. Despite the close phylogenetic 
relationship of E. coli to STm, the mechanisms of phosphonate degradation 
differ between these organisms. E. coli uses the C-P lyase pathway, a relatively 
non-specific mechanism whereas STm uses the phosphonatase pathway [161, 
232, 233, 238]. These observations suggest that the utilization of phosphonates 
is important for the biology of these similar organisms. Whether STM3602 and 
PhnF share regulatory targets remains unknown.  
 NTS use the TTSS-1to invade normally non-phagocytic intestinal 
epithelial cells and induce a strong neutrophilic inflammatory response [51, 77, 
173]. The great importance of this virulence island is illustrated by the fact that 
salmonellae lacking a functional TTSS-1 are avirulent in calf, pig, and mouse 
models of infection [28, 47, 51, 173]. The regulatory network controlling the 
expression of the TTSS-1 is intricate. Transcriptional regulation is carefully 
controlled by regulatory proteins encoded both within SPI-1 and located 
elsewhere on the chromosome [186]. The master regulator of the TTSS-1, hilA, 
is encoded within SPI-1 and integrates regulatory input from numerous sources 
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to activate operons necessary for the production of protein components of the 
TTSS-1 and its associated effectors (reviewed in [239]).  
 We have shown a minor role for STM3602 in the regulation of SPI-1 and 
invasion of tissue cultured epithelial cells. However, competitive infection of the 
double mutant in ∆STM3602 ∆SP1-1 vs ∆SPI-1 exhibited a colonization defect in 
ligated ileal loops in calves (Figure 4.3), suggesting that inadequate activation of 
SPI-1 does not fully explain the observed phenotype. However, the role of 
STM3602 in regulation of SPI-1 remains an interesting area of further study to 
contribute to the breadth of knowledge on this essential virulence mechanism. 
 In the study we report here, we have confirmed that STM3602 is needed 
for colonization of the mammalian intestine. We report that a deletion mutant 
lacking STM3602 grows poorly with PA as a sole phosphorus source and that 
STM3602 has no effect on the expression of phnA, the enzyme required for 
utilization of this compound. Finally, we show that STM3602 plays a minor role 
in the regulation of the TTSS-1.  
Phosphonates are compounds that are produced by microorganisms and 
have been identified in the intestine of mammals. Further studies evaluating the 
role of STM3602 in co-culture with microorganisms known to produce diverse 
phosphonates will elucidate the full complement of compounds to which this 
regulator responds. In addition, definition of the regulon of STM3602 may 
elucidate novel mechanisms for phosphonate transport or utilization in the large 
complement of genes of unknown function scattered within the genome of STm. 
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CHAPTER V 
CONCLUSIONS AND FUTURE DIRECTIONS 
 
 The first genome sequences of Salmonella enterica were published in 
2001, one of the host-generalist serotype Typhimurium [129], and the other of 
the human host-specific serotype Typhi [240]. The availability of these genome 
sequences ushered the study of Salmonella into the genomic era. The 
availability of two genome sequences from organisms with different host 
specificity and disease presentation allowed the development of hypotheses as 
to the similarities and differences between these two serotypes, an area of 
ongoing research. It is clear from comparison of genome sequences of the 
serotypes causing enteric and systemic disease that there are specific genetic 
requirements for survival in these niches [241]. Further work comparing the host-
specific systemic serotypes may define gene signatures important for host-
specific colonization. These types of analyses provide framework to 
experimentally test hypotheses regarding host- and niche-specificity with the 
ultimate goal of development of new therapeutics to combat this pathogen. 
 Approximately 25% of the genome of STm contains genes that are 
absent in close phylogenetic relatives. It has been hypothesized that these 
genes are necessary in the lifecycle of Salmonella in the environment and in the 
host, and some may be necessary for growth and virulence STm during infection 
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[97]. To test this hypothesis, a library of ~1000 mutants in Salmonella-specific 
genes was constructed and used to for systemic infection of Salmonella-
sensitive mice. This carefully designed genetic screen identified 52 genes 
predicted to be important for systemic infection in mice, not including those in 
known virulence determinants. In the work described here, the same library was 
used to test the hypothesis that STm uses specific genes for early colonization 
of the intestine of the calf, a natural host of Salmonella [106]. In this screen a 
total of 54 genes of predicted necessity during early enteric infection were 
identified. Of these, 31 were in genes not previously reported to be essential for 
enteric infection, and 21 not previously predicted to be needed for this purpose. 
Not surprisingly, only 7 genes outside of known virulence pathways were 
predicted to be necessary for both enteric and systemic infection.  
 From direct comparison of the results of these two genetic screens that 
used the same starting library and same methodology for evaluating mutant 
abundance in the pool, we have gained insight into the genes necessary for 
Salmonella to cause enteric and systemic infection. Similar work has been done 
by another group using highly complex transposon-insertion libraries to identify 
host-specific colonization genes [100, 105]. However, these studies lack 
experimental verification in the target animal species, making it difficult to 
determine the relative importance of each predicted gene as a host-specific 
factor. Unfortunately, the extreme differences between calf ligated ileal loops 
and mouse systemic infection preclude the assignment of each of these genes 
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into host- or niche-specific colonization requirements. Further work is needed to 
test the hypothesis that the genes predicted to be niche-specific by these 
screens are, in fact, niche-specific and do not represent host-specific 
colonization factors. The candidate genes needed for colonization of both 
mammalian hosts warrant further exploration to determine their function as they 
likely represent good targets for development of therapeutic interventions that 
may be extrapolated to other mammalian hosts. 
 Surprisingly, one of the genes needed during both bovine and murine 
infection encodes a putative reverse transcriptase. This gene was of immediate 
interest to us, because reverse transcriptases are known to be essential for the 
pathogenesis of retroviruses, but had not previously been described in the 
pathogenesis of bacteria. The STm reverse transcriptase is encoded on a 
horizontally-acquired operon called a retron that makes a covalently linked RNA-
DNA hybrid molecule. This molecule, multicopy single-stranded DNA (msDNA), 
has been studied for 30 years, but no known phenotypes have been associated 
with mutants unable to produce the molecule. Using knowledge of the biology of 
the host gastrointestinal tract, we identified the first in vitro phenotype for a 
mutant deficient in msDNA: inadequate growth in anaerobic conditions. This 
phenotype allowed us to determine that msDNA is needed for adequate 
production of over 230 proteins, only during anaerobiosis. This study is an 
example of functional identification of a gene product in the context of infection 
of a host, using the host biology as a guide to discovery and highlights the 
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importance of knowledge of host physiology for the study of bacterial 
pathogenesis.  
 I hypothesize that msDNA, a covalently linked RNA-DNA hybrid molecule, 
represents a new class of regulatory molecules. It is unlikely that msDNA directly 
alters the abundance of more than 230 proteins. A more likely explanation is that 
it exerts its effects by altering a global regulatory process. This molecule may 
bind directly to other nucleic acids or nucleic acid-binding proteins to exert its 
regulatory function. It is possible that this molecule can regulate transcription by 
directly binding DNA in a manner that may or may not depend on the primary 
nucleotide sequence to alter the binding of RNA polymerase or other regulatory 
molecules such as transcriptional regulators or small RNAs. Another possibility 
is that this molecule may bind to mRNA transcripts creating RNA-RNA or RNA-
DNA duplexes that may alter the kinetics of mRNA degradation. It may also 
have a direct effect on translation by binding to rRNA preventing the ribosome 
from forming normally. Finally, it may have an effect on either transcription or 
translation through interaction with a nucleic acid-binding protein and altering the 
function of that protein.  
 The data suggest that msDNA is needed only during growth in the 
absence of oxygen, as deletion of this molecule has no obvious consequences 
during growth under standard aerobic laboratory conditions. msDNA is produced 
in large amounts during exponential growth in both aerobic and anaerobic 
conditions, but has no apparent role in aerobic growth. This suggests that the 
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molecular target of msDNA is not present under standard laboratory conditions, 
but only during anaerobiosis. The role of oxygen in the mechanism of msDNA 
function is a fascinating area for further study. 
 There are numerous potential functional portions of msDNA. It is possible 
that either the RNA or DNA encode the functional region. Additionally, the 
primary sequence or secondary or tertiary structures may relate to the function 
of this molecule. Additional experiments are needed to (i) determine whether the 
RNA or DNA portion of the molecule contain the functional region and (ii) identify 
whether function depends on primary sequence or secondary structure. These 
experiments are essential to elucidate the mechanism of msDNA function.  
 Retrons have been identified in numerous other pathogenic bacteria, 
opening the possibility that inhibition of the reverse transcriptase or of the 
function of msDNA may become a new antimicrobial strategy to combat 
bacterial pathogens in an era of increasing antibiotic resistance [21]. This 
pathway for antimicrobial discovery is particularly attractive because it can use 
the framework set by decades of research into the reverse transcriptase of HIV-
1 and use the hundreds of small molecule libraries that have already been 
generated to inhibit this enzyme. Future mechanistic work on the retrons of 
STm, Typhi, and other enteric pathogens (EPEC, Shigella, Vibrio, etc.) has the 
potential to generate broad-spectrum therapeutics, some of which may have 
already been used in safety trials in people in the context of retroviral inhibition.  
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 I also examined the role of STM3602, encoding a putative transcriptional 
regulator in enteric colonization. There are many classes of transcriptional 
regulators, some affect gene expression of neighboring operons while others 
have trans regulatory properties, some respond to the presence or absence of a 
metabolite while others are activated in a hierarchical fashion. This diversity 
makes transcriptional regulators a challenging class of proteins to study. 
STM3602 shares a conserved domain with a regulator of phosphonate 
metabolism. Though experiments described in this proposal, we have identified 
a role for this regulator in metabolism/utilization of phosphonoacetic acid. The 
importance of this finding during infection of a host remains to be determined.  
 Many questions have arisen from this work. The only phosphonate to be 
identified in the mammalian intestine is 2-AEP. However, to my knowledge no 
studies have surveyed mammalian intestinal contents to determine the full 
complement of these molecules in this niche. Published data suggest that 
organisms that produce these molecules are in the intestine. I hypothesize that 
there are numerous phosphonate species in intestinal contents, produced by 
microorganisms for their antimicrobial effects as well as to store phosphorus, an 
element that may be limited in certain portions of the intestine. Phosphonate-
containing molecules could represent a mechanism of interspecies competition 
in this niche. Second, the complement of phosphonates incorporated into host 
cells is also unknown. It is possible that the host incorporates these molecules of 
microbial origin secreted directly from intestinal microbes or indirectly from feed 
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sources. These molecules in the form of phosphonolipids could increase in 
availability during epithelial damage as a result of Salmonella infection. Finally, it 
remains to be determined whether compounds containing these molecules or 
organisms producing these molecules could have therapeutic roles to clear 
Salmonella from the intestinal tract of an infected animal. Numerous 
phosphonate-containing compounds are in clinical use as antimicrobials (and 
have other functions) and much work has been done to elucidate the 
mechanism of both biosynthesis and chemical synthesis of molecules containing 
a carbon-phosphorus bond.  
 The role of phosphonates in the pathogenesis of enteric salmonellosis 
merits further work. I hypothesize that there is a small contribution of feed 
material to the overall phosphonate content of the host but that the host 
colonized with phosphonate-producing microorganisms will have a greater 
phosphonate content of both ingesta and host tissues. Germ-free mice are a 
valuable resource for these studies. First, it is necessary to determine the 
complement and quantity of phosphonates in ingesta and incorporated into 
tissues of germ free animals. This will determine the relative contribution of feed 
matter to host phosphonate content. Subsequent studies to evaluate the 
contribution of bacteria to the phosphonate content of both ingesta and host 
tissues can be performed through recolonizing littermates with single or multiple 
bacterial species. I believe it is possible to control the phosphonate content of 
intestinal contents and tissues through feeding these compounds directly or 
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through colonization of germ-free mice with phosphonate-producing 
microorganisms. These studies are a necessary start to identify the role of these 
compounds in the pathogenesis of Salmonella as well as the role of STM3602 in 
the colonization of the host.  
 The work presented here is the starting point for the study of new 
strategies used by Salmonella to colonize the host. Salmonella is one of the 
most heavily studied pathogens because it is genetically tractable, has many 
metabolic similarities to the model organism E. coli, and has great importance 
for animal and human health. I have shown that interrogation of the genome 
using carefully chosen animal models of infection will identify new and 
interesting genes needed for colonization of the host in this heavily studied 
organism. This type of study is critical because the number of cases of enteric 
salmonellosis has not changed despite an overall decrease in the number of 
cases of all bacterial foodborne disease [95]. Additionally, there is an emergence 
of invasive NTS that has the potential to cause life-threatening bacteremia [22]. 
Finally, the number of NTS that are resistant to available antibiotics is increasing 
but there is not a corresponding increase in the development of new antibiotics 
[21]. Therefore, further work on pathogenesis using relevant and carefully 
chosen animal models of disease is critical to understand the biology of this 
organism within a host. Each of the genes described in this work represent a 
new target for a therapeutic intervention or a candidate modified live vaccine 
strain. By studying pioneer genes outside the known virulence pathways, there 
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is the opportunity for tangible advances in the field of Salmonella pathogenesis 
with the ultimate goal of reduction in the morbidity and mortality caused by this 
highly successful pathogen. 
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